Issuu on Google+

Industry-led symposia

SEE PAGES 2-4

Congress layout and full exhibitor list

SEE PAGE 18

www.pharmacycongress.co.uk/facebook

@CPCongress

N uk O o. TI W ss.c RA O gre ST N on GI EN cyc RE P rma O ha .p w w w

The Best of Clinical Pharmacy Awards

SEE PAGES 10 &11

April 2014

The Clinical Pharmacy Congress Network

YOUR PROFESSION. YOUR FUTURE.YOUR EVENT. Back for a third year, The Clinical Pharmacy Congress 2014 is set to become the talking point of this year’s clinical pharmacy calendar. Several notable Congress ‘firsts’ are set to be revealed – and all in just a few weeks’ time. Taking place on April 25th and 26th at Excel, London, this leading clinical pharmacy event is packed full of new features – and with more than 120 exhibitors, and an anticipated audience of 2,000 clinical pharmacy professionals, it is an event that just cannot be missed. For the first time ever, the world-class education programme of the 2014 Clinical Pharmacy Congress will be accredited by the Royal Pharmaceutical Society. This development positions the Congress as an accredited provider of pharmacy Continuing Professional Development (CPD). The endorsement also recognises the quality of the clinical pharmacy education and training that has become a signature component of the Congress since its first show in 2012. Accreditation with the RPS means that the event complies with the RPS Accreditation Standards and Criteria, and that participation, together with effective evaluation, will enable visitors to gain skills, knowledge and attributes for their professional development.

Key clinical programme lectures:  Alcohol dependency  Cardiology  Care of the elderly  Children’s medicines  Cognitive behavioural therapy  Cystic fibrosis  Dementia  Diabetes  Gastroenterology  Hepatology  HIV

 Interstitial Lung disease (ILD)  Oncology  Haematology  Ophthalmology  Pain  Palliative care  Parkinson’s disease  Renal Anaemia  Respiratory  Rheumatology  Schizophrenia

Additional sessions will cover:  Technology  Medicines Optimisation

 Leadership  Innovation

Finally, the 2014 Congress will also see the first ever ‘Best of Clinical Pharmacy Awards’, which will celebrate and acknowledge outstanding individuals and teams within the pharmacy profession today.

WORLD-CLASS EDUCATION

In another first for the event, The Clinical Pharmacy Congress will be running a new Innovation and Technology Forum, where delegates will be able to share best practice and demonstrate in real time how innovation and technology is used to boost pharmacy effectiveness and efficiency. Demonstrations on automation in hospitals, as well as technology use in the homecare environment, using social media and ward-based discharge are just some of the highly relevant presentations taking place during this new and welcome addition to the Congress.

In total, the Congress educational programme offers 54 hours and 84 lecture sessions of high quality accredited CPD education – all of which will be delivered by a faculty of world-class speakers. This is thanks to the programme support of leading pharmacy education partners, the Centre for Pharmacy Postgraduate Education (CPPE), the Royal Pharmaceutical Society (RPS) and the Commercial Medicines Unit (CMU). The education programme, which runs over both days of the event, will be delivered through four theatre programmes, as well as a medicines optimisation workshop and the new Innovation and Technology Forum. For the senior professionals attending the event (who include Chief Pharmacists, Medicines Management, Medicines Optimisation and Consultant

Pharmacists) there is a specially-convened Leaders Forum. This offers this elite group of professionals a private area in which to discuss the future of clinical pharmacy, share best practice, and enhance their engagement with commissioning and medicines optimisation groups. A series of round table discussions have also been scheduled, to debate crucial topics such as gathering patient feedback, and effective medicines optimisation. With visitor numbers again expected to repeat the year on year increases seen during previous events, The Clinical Pharmacy Congress has, without doubt, become clinical pharmacy’s best opportunity to meet, network, and share the expertise and insight of its leading players – and all under one roof. The Congress offers an unprecedented opportunity to network, learn and share feedback, and a comprehensive portfolio of over 120 medicines and specialist pharmacy technology and equipment suppliers are booked to exhibit. Among the big names in branded pharmaceuticals attending the show are AstraZeneca, Bayer, Roche, Janssen, Lundbeck, Sanofi and Sandoz while representing the leading generics houses are Actavis and Teva. Specials suppliers – Moorfields and Quantum Pharmaceuticals not forgetting the NHS manufacturing units from up and down the country - as well as a host of specialist business partners will also be on hand to answer any questions you may have. Professional and other special interest pharmacy organisations attending the event include: The Royal Pharmaceutical Society, and the UK Renal Pharmacy Group (UKRPG), as well as employee representative the Pharmacists’ Defence Association. Clinical Pharmacy Congress Director Matthew Butler (pictured) said: “We are delighted to be able to offer visitors to the Clinical Pharmacy Congress such a comprehensive event package. World-class speakers, leading commercial and professional partners, and top professionals in the clinical pharmacy world all want to be part of our event, which is rapidly becoming the place for clinical pharmacists to go to advance their professional practice. We look forward to helping pharmacists exceed their aspirations and ambitions for clinical practice development again at the 2014 show.”

Register to attend at www.pharmacycongress.co.uk Lead education partner: Conference partners:

Education partners:

UK Renal Pharmacy Group

UK Ophthalmic Pharmacy Group

Leadership partner: Café sponsor:

Media partners:

Leader’s Forum sponsor:

Accredited by:


2

www.pharmacycongress.co.uk

Finalists for The Best of Clinical Pharmacy Awards 2014 Announced Finalists for the Chief Pharmacist, Clinical Pharmacist and Pharmacy Technician of the Year have been announced today with so many entries we have shortlisted up to nine finalists in one category. These awards look to celebrate and acknowledge successful individuals within the pharmacy profession. We are delighted to be able to recognise all sectors of clinical pharmacy through these awards which were open to any qualified pharmacy professional irrespective of career level. Clinical Pharmacist of the Year Toby Capstick

Chief Pharmacist of the Year

Pharmacy Technician of the Year

Andrew Davies

Julie Hamer

Director of Pharmacy, North Bristol NHS Trust

Senior Technician, Medicines Management, North Bristol NHS Trust

David Gerrard

Richard Goodman

Rie Hitchmough

Helen Haley

Ray Lyon

Hannah Lee

Vanessa Marvin

Richard Needle

Darren McCormack

Advanced Clinical Pharmacist for Respiratory Medicine, Leeds Teaching Hospital

Senior Clinical Pharmacist, NTW NHS Foundation Trust, Northgate Hospital, Morpeth

Advanced Clinical Specialist Pharmacist – Child Health, University Hospital of North Staffordshire

Deputy Chief Pharmacist, Clinical Services, and Associate Professor, Chelsea & Westminster Hospital NHS Foundation Trust

Chief Pharmacist, Royal Brompton and Harefield NHS Foundation Trust

Chief Pharmacist – Strategy, Sussex Partnership NHS Foundation Trust

Chief Pharmacist, Colchester Hospital University NHS Foundation Trust

Chief Pharmacy Technician clinical Services, Clatterbridge Cancer Centre

Pharmacy Technician, Prince Charles Hospital, Merthyr Tydfil

Pharmacy Technician, Blackpool Victoria Hospital

Rosalind Needham

Alan Pollard

Daniel Paton

Chief Pharmacist, Birmingham Women’s NHS Foundation Trust

Pharmacy Technician, Lincoln County Hospital, United Lincolnshire Hospitals NHS Trust

Lelly Oboh

Cathy Riley

Jennifer Whitefoot

Clinical Pharmacist, Sir Robert Peel Hospital

Guys & St Thomas NHS FT Community Health Services & East and South East NHS Specialist Pharmacy Services Consultant Pharmacist, Care of older people

Alan Wilson

Specialist Clinical Pharmacist, Royal Victoria Hospital, Belfast Health &Social Care Trust

Director of Pharmacy and Medicines Optimisation, South Staffordshire & Shropshire Healthcare NHS Foundation Trust

Lead Medicines Management Technician, Devon Partnership NHS Trust

Scott Savage

Chief Pharmacist, Kettering General Hospital Foundation Trust

David Taylor

Director of Pharmacy and Pathology, South London and Maudsley NHS Foundation Trust

Judith Woolley

North Essex Partnership University NHS Foundation Trust

All delegates are invited to take their seats in the Keynote Theatre on Friday 25th April at 2:15 to see who will win each category. Missed out this year then don’t forget to enter in 2015 – criteria will be available in late summer…


www.pharmacycongress.co.uk

Clinical Pharmacy Innovation of the Year Come and listen to how these innovative projects have been working in practice and how they made a positive impact on clinical pharmacy practice, in the Innovation and Technology Theatre on Friday at 9:45 and 11am.

Sponsored by:

9.45 - 10.45 Superdrug HIV and Hepatitis C Pharmacy Support Service Tim Morgan Pharmacy Manager Superdrug Pharmacy, Newport As a member of HIVPA and BHIVA, I have forged strong cross sector relationships around the country. Working closely with Royal Gwent Hospital, we reviewed how the role of Community Pharmacy could be enhanced in Newport to both reduce waiting times at the hospital pharmacy, and also have a positive impact on patient care and medicine usage through ensuring all prescriptions are clinically checked by a pharmacist with a background in HIV or Hepatitis C medicine. The Superdrug HIV and Hepatitis C Pharmacy Support Service at Newport was launched in response to these opportunities to improve patient care. The service is scalable, and works by patients either ‘walkingin’ with their prescription from their treatment centre, or having their prescription faxed to Superdrug Pharmacy. The medication is dispensed with a waiting time of

Integrated care clinical pharmacists for frail older people in the community Lelly Oboh Consultant pharmacist, Care of older people Guys & St Thomas NHS FT Community Health Services This innovative clinical pharmacy service is part of the Lambeth and Southwark integrated care pathway (ICP) for frail older people. The ICP aims to improve patient independence and experience through personalised and co-ordinated care, early identification and unnecessary hospital admissions. The pharmacy services intends to achieve the same by optimising the use of medicines, improving adherence and understanding of medicines as well as reducing inappropriate polypharmacy and adverse effects. Service is delivered by a small team of pharmacists receiving referrals to undertake domiciliary medication reviews for patients at high risk of medicines related problems (MRPs). Each pharmacist is linked with specific community health teams (Case management, CMDT1, Homeward, SDT2, RRT3 and Re-ablement). However they work collaboratively with integrated care teams, adult social care and care homes to ensure medicines optimisation during prescribing, supply and

Development of the Barnsley Pharmacistled Inflammatory Bowel Disease and Autoimmune Hepatitis clinic in a General District Hospital. Fernando Garcia Fuertes IBD Pharmacist Barnsley Hospital NHS Foundation Trust The results from a third round UK IBD audit in April 2012 were based on the main six IBD standards and included data from more than 90% of acute trusts and health boards. The audit showed that only 10% of pharmacists are involved in IBD outpatient clinics and 12% attended IBD meetings. The audit highlights the need to strengthen the current provision of pharmacy services to IBD patients in the UK. In the UK IBD Standards update 2013 describes that the minimum viable team for a full IBD service include a pharmacist with a special interest in gastroenterology. Therapy with thiopurines (Azathioprine and 6-mercaptopurine) increases the workload of consultants at

approximately 5 to 10 minutes (in comparison to up to an hour at the hospital pharmacy), or a home delivery option is available for patient convenience. To support patient education and medicines optimisation, I have performed over 120 MURs on HIV positive patients, using a template specifically designed for this cohort with a strong focus on interactions, compliance, side-effects, and healthy lifestyle advice. I have also designed an MUR template for Hepatitis C patients, and regularly carry out reviews prior to starting treatment, with particular attention paid to issues that may compromise treatment success. I have designed a monthly checklist for patients collecting their medications and take a personal approach to these discussions. This pharmaceutical support allows many patients to continue with their treatment by overcoming unwanted side effects using effective OTC products, and the patients can be confident that these products do not compromise the success of their treatment. I maintain an anonomised interventions log with over 40 interventions, and regularly communicate with the multidisciplinary teams and speak to prescribers directly to discuss

administration according to the patient’s specific needs Robust screening, assessment and referral processes were developed to identify patients with complex medicines needs that require further intervention by a pharmacist. The pharmacist undertook in-depth patient centred reviews to identify MRPs relating to access, adherence and clinical effects, taking into account patients’ choice and experience. A care plan was formulated in agreement with the patient with follow up visits as required. Drivers for success include the pharmacists’ role extending beyond reviews, to resolving the problems identified in the care plan, liaising with other health and social care practitioners to co-ordinate its implementation as well as nurturing and facilitating partnership working particularly during care transitions. Also the consultant pharmacist providing clinical supervision and timely resolution of multiprofessional/organisational barriers that hinder medicines optimisation. Training clinical and non clinical staff to provide practical interventions to support medicines use to sustain capacity Analysis of 143 (n 276) data showed an average of 9 LTCs4 and 14 medicines per patient. 376 pharmacist interventions were rated according to the likelihood of preventing a hospital

gastroenterology outpatient clinics as this therapy requires initially close blood monitoring for the first four months. The dose is titrated up by the pharmacist accordingly to patient’s drug tolerability and its biochemistry results on a weekly basis for first 2 months then fortnightly for another 2 months. In fact, the statistics shows that approximately fifty per cent of patients starting therapy might develop myelosuppression after two months. A small sample of patients started on azathioprine was randomly selected at BHNFT for the financial year 2011-2012 and the results revealed inconsistent blood monitoring. The gastroenterologists were, however already aware of this inconsistency, and therefore decided to involve clinical pharmacists in drug monitoring, hence the creation of the pharmacist-led IBD clinic in October 2012. Evidence from previous studies from pharmacist-led IBD clinic or Nurse-led IBD clinic has shown improved patient safety. A patient’s satisfaction questionnaire was posted to the 82 patients who attended the Pharmacist-led IBD/AIH clinic at Barnsley Hospital NHS Foundation Trust. The results showed considerable improvement in the quality of service according to patient’s perspective. 97% of the

dose queries, interactions, and the logistics of the service. I am often contacted by the prescribers for advice regarding interactions and co-prescribed medications and have been fortunate enough to attend the HIV clinic on a monthly basis to ensure up to date clinical knowledge. The pharmacy team at Newport enjoy the new challenges that the service has to offer and have been trained to assemble the complex prescriptions safely. The development of my team’s skills allows the service to run smoothly in my absence, and I feel confident that they can support other pharmacists effectively. Both the HIV positive and Hepatitis C patients have the option of home delivery, and we have successfully delivered over 500 prescriptions to locations all over Gwent. The patients are happy that we are giving the utmost respect to confidentiality. Their service has improved significantly, and I am proud to say that not one patient has missed a dose due to pharmacy error. The Royal Gwent Hospital is pleased that HIV outpatients dispensing has been completely removed, and that patients are receiving a service tailored to their needs through the community pharmacy setting.

admission (212 unlikely; 137 possibly; 27 likely). Responses from 26 (n:32) patient surveys showed that 90% felt they had a better understanding of their medicines and 45% felt their health had improved following the pharmacist visit. 53% of patients live alone and 43% reported at least 1 or more problems taking medicines. A significantly high proportion depend on community pharmacists for support with access and adherence. A scoping study will be undertaken to explore their role in supporting medicines optimisation within the ICP. The service has raised the profile of pharmacists as valuable members of MDTs and additional pharmacy resource secured. The model is featured in the DoH Now or Never Report. Video clip on http://www.rpharms.com/models-of-care/modelsof-care-in-action.asp. Pharmacists in Ireland and Lewisham have adopted this model and receive support through sharing tools, regular teleconferencing and meetings. We have been consulted for advice on similar initiatives in Bromley, Islington and Croydon and invited to share our experience at the RPS Innovators Forum. A poster was presented at the GHP/UKCPA National Conference 2013. CMDT- community multidisciplinary teams SDT- supported discharge team RRT- rapid response team 4 LTC- long term conditions 1 2 3

responders considered that the clinic has improved their care and 63% scored the overall service as excellent. Indeed, 86% of responders scored the clinic above acceptable service. The results of the questionnaire have showed a very good improvement of patient’s care from patient’s perspective so IBD pharmacist-led clinic is a successful service for improving quality in IBD patients. Indeed, the role of the IBD Pharmacist contributed in the development of the gastroenterology role at two levels by liaising pharmacy from wards to outpatient’s clinic. Consequently, the IBD pharmacist was invited to attend the monthly multidisciplinary IBD meeting with surgeons, gastroenterologist consultants, radiologist, stoma specialist nurse and GI lower specialist nurse on a regular basis, so contributing with a specialist pharmaceutical input. Last but not least, the successful Pharmacist-led IBD/AIH clinic has managed to submit one abstract to UK-Clinical Pharmacist Conference 2014 about the first year experience of our 82 patients who attended the clinic and a second Abstract to the British Society Gastroenterology Conference 2014 about our 12 months clinical experience.

3


4

www.pharmacycongress.co.uk

11.00 - 12.00 A clinico-ethical framework for multidisciplinary review of medication in nursing homes

The findings were discussed within a multidisciplinary team (MDT), and proposed interventions were discussed with the resident and/or their family. The final agreed outcomes were documented in the resident’s clinical notes.

Nisha Desai Senior Clinical Pharmacist for Frail Elderly Services Pharmacy Department, Northumbria Healthcare NHS Foundation Trust

The medicines optimisation process Review • Medicines screen & review by pharmacist MDT • MDT discussion: • GP • Pharmacist • Care home nurse Shared Decisions • Patient, family & carers involved in any decisions Follow up • Hotline for urgent advice • Follow up

Medicines use in care homes has been identified as an area of concern by a recent Health Foundation and Age UK report (‘Making Care Safer’): • Excess medicines (sometimes inappropriate) • Lack of structured review of medicines • Communication issues: many residents were unaware of what treatment they are on • Long medication rounds and timing of rounds not resident centred Our project delivers a multidisciplinary team approach to medicines optimisation in care homes, ensuring that all patients or their family/carers were fully involved in decisions made about medicines. Pharmacists undertook detailed reviews using the resident’s clinical (primary care) and care home notes ensuring that all medicines prescribed have a clear and documented indication, are safe and clinically beneficial. A care home team was established and roles agreed for pharmacist, general practitioners, care home managers/nurses and psychiatry team (consultant, nurses, challenging behaviour team).

Pharmacists Writing Discharge Medication Prescriptions at King’s College Hospital (KCH) Raliat Onatade Deputy Director of Pharmacy Clinical Services, King’s College Hospital NHS Trust Initiative: KCH is a 1,000 bed teaching hospital in South London. On average, approximately 2,600 discharge prescriptions (TTAs) are processed monthly. This innovative clinical pharmacy service involves pharmacists at KCH taking full responsibility for writing patients’ discharge medication lists (‘drug lists’). This has revolutionised the process for TTAs across the Trust and enabled us to solve a problem which most hospitals have struggled with. Benefits: The benefits of this approach are increased quality and safety, reduced discharge delays, improved efficiency, fewer communication problems, better use of Patient’s Own Drugs (including home supplies), fewer patient complaints and increased staff satisfaction. Patients benefit from better quality discharge and increased opportunities to discuss their

Theatre Admissions Lounge (TAL) Pharmacy Team Nick Haddington Lead Pharmacist Education and Training Ade Ukoha, Denise Reeves, Julia Nicholls Great Western Hospitals NHS Foundation Trust (Swindon) The Pharmacy Theatre Admissions Lounge (TAL) team represents a highly successful innovation in clinical pharmacy. Prior to implementation of this new service, elective orthopaedic patients admitted via the TAL on the morning of surgery, were then taken directly to the operating theatre and subsequently to the elective orthopaedic ward without having their regular medicines accurately recorded or prescribed on their inpatient drug chart, as there was no opportunity to do this in the pre-operative assessment clinic. As the busy ward-based orthopaedic doctors were often unable to immediately visit patients to prescribe their medicines post-operatively, patients were regularly left

Data 362 patients reviewed across 14 care homes. 945 interventions made. Most common intervention (54.1%) was 512 medicines stopped in 219 patients (61%) An average of 1.4 medicines stopped for every patient reviewed (range 0 to 9 medicines stopped) There was 15% reduction in medicines use over the course of the project in the 362 patients. Total annualised savings from stopping medicines = £55,176.

discharge medication with pharmacists. Proactively writing drug lists is a better use of pharmacists’ skills, rather than simply correcting doctors’ prescribing mistakes. It also enables pharmacists to improve their clinical decision-making skills, as a precursor to actual prescribing. Method: The pharmacist as part of their routine ward duties is told which patients are going home within the next 24 hours. They write the list of medication that the patient will continue at home (in discussion with the doctor and patient). They also ensure that medication changes and monitoring requirements are documented. Required items are dispensed. The medication is sent back to the ward, with instructions to staff not to issue to the patient until the clinical summary is completed. The doctor writes the clinical summary in their own time, checks the drug list and informs the pharmacist if any changes need to be made. Once confirmed by the doctor, ward staff print out the full TTA (clinical summary and medication list) and give to the patient with medication. The service is active in all areas Monday to Friday, and in acute admissions on Saturdays and Sundays. We monitor our performance by collecting data and can demonstrate

without their medicines prescribed, and therefore at high risk of having their regular medication unintentionally omitted. A model of care was proposed to the Trauma and Orthopaedics department in which Pharmacist Independent Prescribers would attend the TAL each day to complete a consultation with each elective orthopaedic patient; completing medicines reconciliation and prescribing the patients’ regular medicines within the local policies for the peri-operative management of medicines. This was successfully implemented as an initial pilot in April 2013, and subsequently reviewed and granted substantive ongoing funding. The process for implementation of this new clinical pharmacy service involved wide discussions with a range of key stakeholders including the orthopaedic consultants, the consultant anaesthetists, and senior nursing staff overseeing the Pre-admission clinic, TAL and the orthopaedic ward. After due consultation, a service protocol was ratified by the Trust Prescribing Committee.

63 medicines started at the cost of £2,872, net saving of £52,304. Service costs (Pharmacy, GP and Psychiatry time) have been in the region of £26,000. For every £1 invested, £2 can be saved from the medicines budget. Patient Involvement Patient involvement was not possible for all residents and some residents had no family; a patient involvement framework was developed. 280 residents have been mapped against this framework, with only 47 residents (17%) being able to be actively involved in decisions about their medicines. Our learning Our results show that pharmacists working within a MDT can make a number of interventions to improve the quality and safety of prescribing for care home residents. We have demonstrated the process is reproducible in residential and nursing care homes. We have incorporated and tested different methods of GP engagement to suit the practices involved, preferred model with GP participation within the MDT but also effective with pharmacist discussing proposed interventions with GP following the MDT. Quotes Having done the SHINE I think it is an excellent model. It really made me think, involving the family is a really good idea. I suspect a lot of them don’t mind the changes you have made but it is very positive to have them involved. I think it helped to improve the relationships with the care home. GP involved in a SHINE Care Home Review

that since 2012/13, including weekends, pharmacists are responsible for at least 70% of all discharge medication orders. However, considering Mondays to Fridays only, pharmacists write over 80% of all discharge medication lists. Initially, we wrote 30% of TTAs but the service was so popular we were asked to maximise our input. We are currently introducing the service at our newly acquired hospital in Bromley. First year pharmacists do not participate in writing drug lists, and all other pharmacists have to undergo a competency assessment first. We have conducted several small audits to review the accuracy and efficiency of the service. The service is largely time-neutral compared to the traditional method of screening doctor-written TTAs. We are now completing a large, definitive quality audit demonstrating that pharmacists’ drug lists have minimal errors. This data can be presented if we are shortlisted. The service is highly valued by Trust staff and senior managers. Although we mainly introduced it without extra resources, funding has been made available where needed. We believe we are the only pharmacy department in the UK to routinely provide this clinical service across a whole hospital.

A large and statistically significant increase was seen in the number of patients having their regular medicines prescribed on the day of admission, from 46% before to 91% after implementation of the service. A survey measuring patient experience found very high levels (98%) of patient satisfaction with the service.* This new service has successfully implemented a novel role which utilises the advanced generalist skills of experienced clinical pharmacist prescribers in a busy elective admissions setting, and has the potential to be applied in other admissions settings both within the Trust and in other organisations. The service has resulted in the deep integration of the clinical pharmacy service into the Trauma and Orthopaedics department involving close multidisciplinary working with nursing, orthopaedic and anaesthetics healthcare professionals. This has resulted in enhanced recognition within the Trust of the value that the clinical pharmacy team can add to patient care. *Please note that this data is contained within a paper that we have submitted for publication and is currently under consideration.

Missed out this year then don’t forget to enter in 2015 – criteria will be available in late summer…

Register NOW at www.pharmacycongress.co.uk


www.pharmacycongress.co.uk

5

KEYNOTE THEATRE

Anne Cole

Ann Slee

Dave Branford

FRIDAY 25TH APRIL

9.00 – 9.30

The Chief Pharmaceutical Officers’ Address – An update from NHS England April 2014 will mark the one year anniversary for NHS England. Clare Howard, Deputy Chief Pharmaceutical Officer will describe the Medicines Optimisation strategy and the progress that has been made to date. Clare will outline how Clinical Pharmacists and technicians can play their part in ensuring that patients get more from their medicines and why its so important that they do. You will hear how patients have described their experience with medicines especially for long term conditions and how we need to adapt our services and the way we work to better meet their needs. There will be an opportunity to ask questions about this important strategic agenda. Clare Howard, Deputy CPhO, NHS England

In association with: Lunch Symposium – Update on NOACs and on-going clinical trials. When are warfarin and aspirin not suitable (with patient-profile examples on how we manage a patient)?* This session will primarily cover stroke prevention in atrial fibrillation with a focus on the current uptake of non-VKA oral anticoagulants (NOACs) across the UK. Cover the anticipated NICE AF guideline and the work on the NICE implementation collaborative with real cases of when warfarin and aspirin are not suitable and possible choices for managing these patients. Lastly highlight the ongoing clinical trials associated with NOACs. Helen Williams MRPharmS PGDip(Cardiol) Ipresc, Consultant Pharmacist for Cardiology, Lambeth & Southwark CCG, London and Sotiris Antoniou RPS MSc DipMgt IPresc, Consultant Pharmacist, Cardiovascular Medicine, Barts Health NHS Trust Delivered by: 14.15 – 14.45

utts Christopher C

David Alldred

SATURDAY 26TH APRIL

Respiratory medicine – what’s new? In this session Anna will provide an update on the pharmacological management of respiratory diseases. She will aim to provide an overview of recent significant clinical research in respiratory 10.00 – medicine relevant to pharmacists, an update of any changes to national respiratory guidelines and 10.45 an insight into new and future drugs and devices. Dr Anna Murphy, Consultant Respiratory Pharmacist, Cardio-respiratory Directorate, University Hospitals of Leicester NHS Trust Dementia Friends information session – become a Dementia Friend The Dementia Friends programme aims to increase awareness and understanding of dementia by educating one million people to become Dementia Friends by March 2015. • people with dementia sometimes need a helping hand to go about their daily lives and feel included in their local community • a Dementia Friend is someone with an understanding of dementia and the small things that they can do that could make a difference to people living with 11.30 – 12.15 dementia • There is an ambition for everyone who works in pharmacy to become a Dementia Friend. CPPE are working with other pharmacy organisations and Dementia Friends to facilitate this. At this session you will become a Dementia Friend and find out how you can improve the lives of people living with dementia in your community. Anne Cole, Regional Manager South West, CPPE

12.45 – 13.30

Roger Knaggs

THE BEST OF CLINICAL PHARMACY AWARDS

Presented by Clare Howard and Chris Cutts

ePrescribing and medicines administration – Delivering a paperless NHS The uptake of ePrescribing and Medicines Administration (eP) in to hospitals in England has been slow with only 13% of hospitals having implementation across inpatient prescribing in 2011. The announcement of the Safer Hospitals Safer Wards fund in 2013 re-emphasised the benefits and 15.00 – priority attributed to its rollout as part of a paperless NHS. The session will look at the fund, its 15.45 aims and how it is progressing. It will also identify how NHS England is looking to support Trusts in realising the successful delivery of ePrescribing. Ann Slee, ePrescribing Lead, Strategic Systems and Technology, Patients and Information, NHS England ‘Now or Never’ six months on The presentation will provide an overview of the RPS ‘Now or Never’ Report and the progress in 16.15 – implementation of its recommendations. 17.00 Dr David Branford, Chairman, English Pharmacy Board, Royal Pharmaceutical Society Improving outcomes for patients suffering acute myocardial infarction – the role of medicine optimisation Cardiovascular disease remains the largest reason for premature mortality in the UK. This presentation will explore recent advances in the management of acute coronary syndrome including 17.15 – pharmacotherpeutics during the interventional procedure and the importance of secondary 18.00 prevention. Duncan McRobbie, Associate Chief Pharmacist and Lead Cardiovascular Pharmacist, Guy’s and St Thomas’ NHS Foundation Trust and Visiting Professor, UCL School of Pharmacy

9.00 – 9.30

10.00 – 10.45

11.15 – 12.00

Keynote address: Pharmacists role in tackling Antimicrobial Resistance Antimicrobial resistance (AMR) is a major clinical and public health issue and an important threat to the future of healthcare. The Chief Medical Officer’s report and the UK 5 year AMR strategy set out the Government’s priorities and objectives in tackling AMR. In addition, the Royal Pharmaceutical Society’s Professional Standards for Public Health will include antimicrobial stewardship. All Pharmacists and Pharmacy Teams have a significant role to play in tackling the threat of AMR. This session will set out what pharmacists from all sectors can do. Dr Diane Ashiru-Oredope, Pharmacist Lead AMRS & HCAI, Public Health England and DH Advisory Committee on Antimicrobial Resistance and Healthcare Associated Infection (ARHAI) Breakfast Symposium delivered by Janssen* (Diabetes) Update on renal anaemia This presentation will cover the causes and diagnosis of renal anaemia, and discuss the therapeutic options for the management of the condition. In light of the recent update of NICE guidelines for the management of renal anaemia, we will look at some of the evidence behind the latest recommendations, as well as discussing the guidelines themselves. We will also look at the use of supportive therapies including intravenous iron. Caroline Ashley, Lead Pharmacist Renal Services, Royal Free London NHS Foundation Trust In association with:

UK Renal Pharmacy Group

Promoting self management of persistant pain For patients and healthcare professions alike persistent pain problem can be difficult to understand and manage. Many people completing a pain management programme say ‘if only someone had told 14.00 – me all this earlier!’ and intervening earlier in the ‘pain cycle’ might prevent some people’s descent into a life dominated by pain. Most analgesic medicines work well but for only a small proportion 14.45 of patients and it is essential for patients to understand their condition and how they can work together with healthcare professionals, including pharmacists, to ensure optimum outcomes. Roger Knaggs, Associate Professor in Clinical Pharmacy Practice, University of Nottingham and Nottingham University Hospital NHS Trust Fragility – Managing the use of medicines in care homes including an update on the new NICE managing medicines in care homes guidance This presentation will discuss the evidence-base around medicines use in care homes for older people with an emphasis on quality and safety. Key aspects of the newly published NICE guidance 15.15 – on managing medicines in care homes will be presented. 16.00 Dr David Alldred, Senior Lecturer in Pharmacy Practice, University of Bradford and member of the NICE Managing Medicines in Care Homes Guideline Development Group In association with: Cystic Fibrosis and the transition between children and adults This session will cover the basics of cystic fibrosis, its complications and its treatment from birth to adulthood, including new treatments recently introduced to market. The role of the CF pharmacist 16.15 – and CF specific medicines management issues will be highlighted. 17.00 Dr Amanda Bevan, Divisional Pharmacist – Family Health, Southampton Children’s Hospital In association with:

Free drinks reception

*This Congress is supported by educational grants from various companies who have not influenced the meeting content or the choice of speakers however those sessions marked with an asterisk (*) are being delivered with input from the sponsoring company. Please note: This programme is subject to change as speakers & session titles are confirmed - this is a working document.

The Congress will be hosting a networking drinks reception once again on Friday 25th April (18:00 – 19:30) at the show floor café, providing the perfect opportunity to relax after a busy day and network with other pharmacy professionals.

Refresher

Advanced Free Lunch Hot Drink & Pastry

Register NOW at www.pharmacycongress.co.uk


6

www.pharmacycongress.co.uk

LEADERSHIP THEATRE

bie Duncan McRob

Adam Mapani

s

Ellen William

FRIDAY 25TH APRIL

10.00 – 10.45

11.30 – 12.15

15.00 – 15.45

16.15 – 17.00

Catherine Dug

Suzanne Khalid

gan

SATURDAY 26TH APRIL

Supporting leadership The presentation will outline the challenges facing us across all sectors in today’s practice and the need for us to support and develop leadership at all career stages. The presentation also outlines ways in which we can do this alongside the professional development opportunities for all stages across all sectors. Catherine Duggan PhD FRPharmS, Director of Professional Support and Development, Royal Pharmaceutical Society Leading quality improvements We all want to provide the highest quality of care for the patients we serve. Leading quality improvements in healthcare can be challenging, slow, daunting yet exciting. This session will describe the top ten challenges people face when leading quality improvement initiatives. At the end of the session, you will have a better understanding of approaches you can use to address these challenges and the session will give you some take away tools and techniques to help you design and plan your next improvement intervention. Suzanne Khalid, Associate Director of Quality Improvement and Director Clinical Support and Imaging Services, University Hospital of Leicester NHS Trust “No more money in the drug budget” managing the team and delivering the service Duncan McRobbie MSc FRPharmS, Associate Chief Pharmacist and Lead Cardiovascular Pharmacist, Guy’s and St Thomas’ NHS Foundation Trust and Visiting Professor, UCL School of Pharmacy Ready for the call? Inspiring leadership within a new profession The demand for pharmacy services at the front line is ever increasing, consequently so is the pressure on our pharmacists, so getting the skill mix of the pharmacy team right has never been a bigger priority. Ensuring the roles and responsibilities of the pharmacy services are delegated to appropriately trained members of the team and that the supervision model is right will be key to making this happen. Strong leadership is going to be essential to the future and success of these initiatives. How can pharmacy technicians take up the baton and act as leaders in their new profession? Catherine Davies MAPharmT, Education Officer - Development, APTUK and Ellen Williams MAPharmT, Joint Editor, ‘Pharmacy Technician Journal’, APTUK In partnership with:

17.15 – 18.00

p

Nicola Dunlo

One year after Francis, Berwick and Keogh Richard Cattell, Director of Operations, Dudley Group NHS Foundation Trust

11.15 – 12.00

Managing complexity Richard Cattell, Director of Operations, Dudley Group NHS Foundation Trust

Clinical leadership by allied professionals at Moorfields Eye Hospital NHS Foundation Trust Moorfields Eye Hospital is a specialist ophthalmic centre and manages a significant cohort of patients from across the UK with complex ocular inflammatory disease. As part of the strategy to provide high quality care for patients, extended roles for allied professionals within specialist fields are evolving and some are innovating to improve patient care and experience. This presentation explores three clinical projects led by allied professionals at Moorfields : Nurse intravitreal injection service; Development of an interactive DVD on Thyroid Eye Disease and its management ; Pharmacy 14.00 – Darzi project on medicines optimisation through near patient activities and implementing a 14.45 comprehensive management and monitoring system for patients on immunosuppressants for ocular diseases. Mildred Johnson BSc DipClinPharm MRPharmS, Head of Clinical Pharmacy Services, Nicola Dunlop MSc PGDip NMP EBN RGN, Advanced Ophthalmic Nurse Specialist / Lead Nurse Adnexal Service, Adam Marpani BSc MSc BA RGN, Advanced Ophthalmic Nurse Specialist/Lead Nurse Medical Retina Service and Amani El-Bushra BPharmS DipClinPharm MRPharmS, Darzi Fellow in Clinical Leadership and Specialist Pharmacist all Moorfields Eye Hospital NHS Foundation Trust Why research is important to my clinical practice Is integrating research into practice merely an aspiration? Grainne will describe her career path (past, present and future aspirations) outlining her motivations for being a clinical practitioner trying 15.15 – to get more involved with research, the opportunities she has experienced and why she feels “clinical 16.00 academia” is where it’s at… Grainne d’Ancona MRPharmS MSc Iprescr, Principal Pharmacist and Honorary Clinical Lecturer, NIHR Research Fellow, Guys and St Thomas’ NHS Foundation Trust Building your portfolio An overview to the RPS Faculty and building your portfolio according to the Advanced Pharmacy 16.15 – Framework. The session will explain how this fits with CPD, Continuing Fitness to practice and with your own professional development. The session will also cover how to use the RPS’ electronic 17.00 Advanced Practice Portfolio so bring your laptop and RPS log in details to gain the maximum benefit! Hannah Wilton, Faculty Development Lead, Royal Pharmaceutical Society

PHARMACY TECHNICIAN FOCUS

The following sessions have been created with the entire pharmacy family in mind. They are designed to be of interest and relevance to all pharmacy professionals, including pharmacy technicians. FRIDAY 25TH APRIL

11.30 - 12.15, Keynote Theatre Dementia Friends information session – become a Dementia Friend, Anne Cole, Regional Manager South West, CPPE In association with: 15.00 - 15.45, Keynote Theatre Cancer medicines…access in the new NHS!! Jacky Turner BSc MMedSci MRPharmS, Principal Oncology Pharmacist and Area Team Cancer Pharmacist, Guy’s and St Thomas’ NHS Foundation Trust and NHS England Area Team (London) In association with: 16.15 - 17.00, Leadership Theatre Ready for the call? Inspiring leadership within a new profession Catherine Davies MAPharmT, Education Officer - Development, APTUK and Ellen Williams MAPharmT, Joint Editor, ‘Pharmacy Technician Journal’, APTUK In partnership with: 10.00 - 10.45, Medicines Optimisation Workshops Consultation skills – improving your performance Dr James Desborough MPharm MRPharmS PhD PGCertHE, Lecturer in Pharmacy Practice, University of East Anglia, Nina Barnett MSc FRPharmS FFRPS IPresc JP, Consultant Pharmacist, Care of Older People, North West London Hospitals Trust and East and South East England Specialist Pharmacy Services NHS and Lesley Grimes MRPharmS, Senior Pharmacist, Learning Development, CPPE, University of Manchester

11.30 - 12.15, Medicines Optimisation Workshops Transfer of care: Safely HERE, Safely THERE Alistair Gray MRPharmS BSc (Hons), Clinical Services Lead Pharmacist, East Lancashire Hospitals NHS Trust and Rebecca Morgan BPharm, Intermediate Care Pharmacist, Central Manchester University Hospitals NHS Foundation Trust 15.00 - 15.45, Medicines Optimisation Workshops Inhaler technique Dr Anna Murphy MRPharmS (IP) Dpharm, Consultant Respiratory Pharmacist, Cardio-respiratory Directorate, University Hospitals of Leicester NHS Trust 16.15 - 17.00, Clinical 1 Theatre Care homes and supporting safer medicines Lelly Oboh MPharmS Ipresc PGDip Clin Pharm, Consultant Pharmacist, Care of Older People, Guys & St Thomas Community Health Services and East and South East NHS Specialist Pharmacy Services

SATURDAY 26TH APRIL 14.00 - 14.45, Keynote Theatre Promoting self management of persistant pain Roger Knaggs, Associate Professor in Clinical Pharmacy Practice, University of Nottingham and Nottingham University Hospital NHS Trust 15.15 - 16.00, Leadership Theatre Why research is important to my clinical practice Grainne d’Ancona MRPharmS MSc Iprescr, Principal Pharmacist and Honorary Clinical Lecturer, NIHR Research Fellow, Guys and St Thomas’ NHS Foundation Trust

11.15 - 12.00, Clinical Theatre Pharmaceutical care of the end of life patient Ray Bunn, Community & Specialist Palliative Care Pharmacist 14.00 - 14.45, Clinical Theatre The role of the neurology specialist pharmacist in the management of Parkinson’s Disease Dr Janine Barnes MRPharmS PhD IPres PhwSI (Neurology), Neurology Specialist Pharmacist, NHS Dudley CCG 14.00 - 14.45, Medicines Optimisation Workshops Inhaler technique - identifying problems and proposing solutions Margaret Allan BPharm(Hons), Acting Director, Wales Centre for Professional Pharmacy Education (WCPPE) and Sarah Ridgway Green MRPharmS MBA, Regional Manager for South East Coast, CPPE 15.15 - 16.00, Medicines Optimisation Workshops Consultation skills – improving your performance Chris Cutts, Director, CPPE and Lesley Grimes MRPharmS, Senior Pharmacist, Learning Development, CPPE, University of Manchester 16.15 - 17.00, Medicines Optimisation Workshops Optimising the use of medicines in older people during transfer of care Lelly Oboh MPharmS Ipresc PGDip Clin Pharm, Consultant Pharmacist, Care of Older People, Guys & St Thomas NHS Trust Community Health Services and East & South East NHS Specialist Pharmacy Services

*This Congress is supported by educational grants from various companies who have not influenced the meeting content or the choice of speakers however those sessions marked with an asterisk (*) are being delivered with input from the sponsoring company. Please note: This programme is subject to change as speakers & session titles are confirmed - this is a working document.

Refresher

Advanced

Register NOW at www.pharmacycongress.co.uk

Free Lunch


www.pharmacycongress.co.uk

CLINICAL THEATRE

Anja St.Clair

Jones

n

Sharron Gordo

Sponsored by:

Tina Hawkins

FRIDAY 25TH APRIL 10.00 – 10.45

7

eld

Simon Whitfi

Ray Bunn

Dan White

SATURDAY 26TH APRIL

Anti-microbials and infections Philip Howard BPharm(Hons) DipClinPharm Ind Presc MRPharmS, Consultant Antimicrobial Pharmacist, Leeds Teaching Hospitals NHS Trust

Mission remission: Access, evidence and immunology – is remission achievable for rheumatoid arthritis patients when methotrexate is no longer appropriate?* 11.30 – Caron Underhill, Biologics Pharmacist, University Hospital Southampton NHS Trust and Professor Ernest Choy, Head of Rheumatology and Translational Research 12.15 Institute of Infection and Immunity, Cardiff University School of Medicine Delivered by: Cancer medicines…access in the new NHS!! The NHS in England is developing rapidly, with significant changes to the structures commissioning health services. The annual spend on cancer is rising and the Cancer Drugs Fund has increased access to cancer medicines. It is clear that commissioning of chemotherapy via the NHS England will have a significant impact on funding systems and processes which will need to be in place at Acute 15.00 – Trust and commissioner level as we move forward. This session describes changing NHS structures in relation to the commissioning of cancer and medicines. It will also provide an update on the 15.45 National Cancer Drugs Fund. Jacky Turner BSc MMedSci MRPharmS, Principal Oncology Pharmacist and Area Team Cancer Pharmacist, Guy’s and St Thomas’ NHS Foundation Trust and NHS England Area Team (London) In association with: Alcohol dependency – the problem, care pathways and new treatment opportunities for providers* This presentation gives an overview of the following: • The current burden presented by alcohol dependence in England, including the impact on NHS resources • The different thresholds and classification systems for establishing the severity of alcohol dependence • The current service providers, treatment pathways 16.15 – and interventions used including pharmacological abstinence strategies • The gaps in 17.00 current treatment pathways • Opportunities for earlier intervention including the new pharmacological treatment nalmefene and its place in therapy • Opportunities for existing and new providers to support this public health agenda including a role for community. Simon Whitfield Clin Dip Bpharm MRPharmS, Chief Pharmacist, Surrey & Borders Partnership NHS Foundation Trust Delivered by: Bridging the divide – pharmacy, psychology and non-adherence Dan White is a specialist clinical pharmacist and cognitive behavioural psychotherapist. In this session he will aim to explain how understanding the psychological concepts involved in nonadherence can lead to an increased effectiveness in strategies to improve medicines optimisation through increased adherence. Recent research provides substantial evidence that adherence can 17.15 – be significantly improved by adopting cognitive behavioural change strategies over and above the 18.00 standard advice and education giving, furthermore that these strategies can be delivered by routine health care professionals, including pharmacy staff. Topics covered in this session will include, exploring frameworks to understand non-adherence, cognitive behavioural interventions to improve adherence and what steps pharmacists can take to implement them. Dan White BSc Pharm (Hons) Dip Clin Pharm PG Dip Cognitive Therapy, Senior Clinical Pharmacist, BABCP Psychotherapist, Honorary Member Dept Psychiatry, University of Oxford, Oxford Health NHS Foundation Trust

Breakfast Symposium – Treating DVT & PE, commissioning services and delivering QIPP – the smart outcome for patient and clinician choice* The session is designed to be as interactive as possible. Providing an opportunity to learn through some formal presentation but also an opportunity to learn through discussions with colleagues around patient case studies. The presentation will provide an overview of current drug therapy and treatment of VTE & PE. Changes in current practice across the country will be discussed and 10.00 – some of the challenges and opportunities presented by these changes, described. Learning will be 10.45 reinforced through case studies and discussions with colleagues. Sharron Gordon MRPharmS, Deputy Chief Pharmacist – Clinical Services, University Hospital Southampton and Frances Akor MPharm PhD MRPharmS IP, Consultant Pharmacist for Anticoagulation, Imperial Health & Chair of UKCPA Haemostasis, Anticoagulation & Thrombosis Committee Delivered by Bayer Healthcare*: Pharmaceutical care of the end of life patient Ray will look at the pharmaceutical care of patients at the end of life in the following areas: 11.15 – • The terminal phase of life • Liverpool & dying Care Pathways - controversies & realities • Symptom 12.00 management in the terminal phase of life • Syringe drivers & the sc administration of drugs • Associated pharmaceutical care issues e.g counselling carers. Ray Bunn, Community & Specialist Palliative Care Pharmacist Lunch Symposium – Almost a century of diabetes control, what next?* Over time, approaches to type 2 diabetes care have evolved and the number of pharmacotherapies at healthcare professionals’ disposal to manage type 2 diabetes has grown. During this symposium, we will review some of the achievements and remaining challenges facing effective management of type 2 diabetes. We will then consider potential ways that you can improve the care available to people with type 2 diabetes in your clinical practice, both in terms of reconsidering therapeutic regimens and the services provided. There will also be an opportunity for you to pose your questions in a Question and Answer session. 12.30 – 13.15 Using recently introduced therapies in clinical practice Dr Rahul Nayar, Consultant in Diabetes and Endocrinology, Sunderland City Hospital Almost a century of diabetes control: achievements and remaining challenges Alia Gilani Bsc (Hons) Bsc (Hons) MRPharmS MPC, Health Inequalities Pharmacist, NHS Glasgow Delivered by: The role of the neurology specialist pharmacist in the management of Parkinson’s Disease The presentation will cover a brief overview of Parkinson’s disease as a condition and then describe the Community Neurology team created within Dudley CCG, the role of the Neurology Specialist Pharmacist, and the management of patients. There will be a reminder of potential dopamine 14.00 – blocking drugs that can mimic the symptoms of Parkinson’s disease, making the condition appear 14.45 worse, and common prescribing problems of Parkinson’s disease medications that have been encountered in primary care. The presentation will finish by describing some of the ongoing research currently being carried out to try to find a cure for the condition. Dr Janine Barnes MRPharmS PhD IPres PhwSI (Neurology), Neurology Specialist Pharmacist, NHS Dudley CCG Current issues in rheumatology Issues to be covered: Potential new treatments for the management of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis • Where are we with evidence to support the sequence of biologic switching in RA? • Once clinical remission is achieved can we withdraw biologic therapy? The presentation aims to build upon the information presented last year at the Congress as part of 15.15 – the session on an “An update on the use of biologic medicines in the management of rheumatoid 16.00 arthritis (RA) and other rheumatological conditions”. The presentation last year focused on current management, this year it will identify new potential therapies for these conditions which may become available in the near future. In the 2013 conference, reference was made to the practice of switching between biologic agents to achieve Tina Hawkins MRPharm Ipresc, Advanced Clinical Pharmacist Rheumatology, Independent Pharmacist Prescriber, Chapel Allerton Hospital, Leeds Teaching Hospital NHS Trust Inflammatory bowel disease update and how can a pharmacist influence medicines optimisation - what does SONIC, TAXIT and STORI tell us IBD is a complex disease which we are still trying to understand. Current research endeavours to stratify patients and therapies identifying subgroups of patients benefitting from personalised 16.15 – treatment strategies. Biologics are expensive and tools to optimise therapies can be of great use to 17.00 improve medicines management over the whole healtheconomie. Trials such as SONIC, TAXIT, STORI and others may help us to develop decision tools but also identify patients that may profit most from specific therapies. Anja St Clair Jones Dip Pharm MSC MRPS, Lead Pharmacist Digestive Disease, BSUH NHS Trust

*This Congress is supported by educational grants from various companies who have not influenced the meeting content or the choice of speakers however those sessions marked with an asterisk (*) are being delivered with input from the sponsoring company. Please note: This programme is subject to change as speakers & session titles are confirmed - this is a working document.

Refresher

Advanced Free Lunch Hot Drink & Pastry

Register NOW at www.pharmacycongress.co.uk


8

www.pharmacycongress.co.uk

MEDICINES OPTIMISATION WORKSHOPS

ugh

James Desboro

Lesley Grimes

Margaret Allan

FRIDAY 25TH APRIL Consultation skills – improving your performance Effective consultations with patients lie at the heart of delivering patient-centred care. The Modernising Pharmacy Careers (MPC) review of post-registration professional development identified development of consultation skills within the medicines optimisation agenda as a priority. The MPC work stream has developed the national practice standards for consultation skills and a six step model to support pharmacy professionals which is hosted on the Consultation Skills for Pharmacy Practice website (www.consultationskillsforpharmacy.com). This interactive session will 10.00 – challenge you to consider your own approach in consultations, how the new standards can support 10.45 your practice and what the new website offers you. Dr James Desborough MPharm MRPharmS PhD PGCertHE, Lecturer in Pharmacy Practice, University of East Anglia, Nina Barnett MSc FRPharmS FFRPS IPresc JP, Consultant Pharmacist, Care of Older People, North West London Hospitals Trust and East and South East England Specialist Pharmacy Services NHS and Lesley Grimes MRPharmS, Senior Pharmacist, Learning Development, CPPE, University of Manchester Transfer of care: Safely HERE, Safely THERE Transfer of care has always been a concern with regards to patient safety in the past but it does not have to be that way in the tomorrow’s world. Key areas to be explored in the session include: the optimal timing of medicines reconciliation, organisational and individual solutions, the influence 11.30 – of the patient’s transfer destination, and the role of community pharmacists (including Refer-to12.15 Pharmacy). Join this interactive debate and explore practical examples and solutions which can help you and your patients now… and in the future. Alistair Gray MRPharmS BSc (Hons), Clinical Services Lead Pharmacist, East Lancashire Hospitals NHS Trust and Rebecca Morgan BPharm, Intermediate Care Pharmacist, Central Manchester University Hospitals NHS Foundation Trust Lunch symposium: The wider role of pharmacists in delivering outcomes in diabetes* Question today is ‘What can pharmacists do to empower people with diabetes?’ The session will be an interactive panel discussion to try and answer this central question. The discussion will help gain insight as to the role of pharmacist in diabetes management now and in the future. 12.45 – Professor Ray Fitzpatrick, Clinical Director of Pharmacy, Royal Wolverhampton 13.30 Hospitals NHS Trust and West Midlands Pharmacist Workforce Chair; Dr David Terry, Senior Lecturer in Clinical Pharmacy, School of Life and Health Sciences at Aston University Birmingham; Mark Robinson, Medicines Management Partnership (London)

n Rebecca Morga

16.15 – 17.00

Funding and managing high cost drugs in the new NHS This session will provide delegates with an overview of the current commissioning of high cost medicines that are the commissioning responsibility of NHS England Specialised Services. The session will include: • an overview of how medicines are commissioned and the governance process which is used to prioritise medicines • a description of how area teams are working with Trusts to identify high cost medicine budgets • interactive scenarios relating to tariff arrangements Paul McManus MSc BSc (Hons) MGPC MRPS, Pharmacy Lead, Specialised Commissioning Team, South Yorkshire and Bassetlaw Area Team, NHS England, Malcolm Qualie MSc BSc (Hons) MGPC MRPS, Pharmacy Lead, Specialised Commissioning, NHS England and Suzy Heafield MSc BSc (Hons) MGPC MRPS, Pharmacy Lead, Birmingham and The Black Country Area and Team Associate: Medicines and Therapeutics, NHS Arden Commissioning Support

Patient perspectives: making it real – Type 2 diabetes and schizophrenia The four principles of medicines optimisation (MO) describe how healthcare professionals can support and engage with patients to improve their quality of life and outcomes from medicines use. The RPS and CPPE have recently produced four MO briefings to help pharmacy professionals put MO into practice in four clinical areas. This session will look 17.15 – at MO in type 2 diabetes and schizophrenia from patients’ perspectives. Patients will talk 18.00 about their experience with medicines and the support they have (or have not) received in relation to making the most from them. We will look at how to engage patients and agree commitments to change. Anne Cole MSc MRPharmS, Regional Manager South West, CPPE and Heidi Wright MRPharmS, English Policy and Policy Head, RPS with John Pottle, Diabetes Patient and Stuart Adams, Schizophrenia Patient

Sarah Ridgway

Green

Lelly Oboh

This new theatre for 2014 will enable a great degree of interactivity between speakers and delegates through cabaret style seating and use of the delegate voting system. These features will ensure you take away as much as possible from these appealing sessions. SATURDAY 26TH APRIL

11.15 – 12.00

Appropriate prescribing and polypharmacy in a multimorbid world What is polypharmacy and when is it appropriate? What impact does multimorbidity have on polypharmacy? What work has been done to address polypharmacy and what is the pharmacists role. What should be addressed in drug review process and what tools can be used to help decision making about appropriate prescribing. How to use risk stratification tools to identify patients that most need reviews. Scotland future delivery of pharmaceutical care for all patients in Scotland: “Prescription for Excellence” Alpana Mair MRPharmS MCPP IP BSc MSc(Pharmacy) MSc( Advanced Leadership) Cert Ed (HE) Dip (Diabetes), Deputy Chief Pharmaceutical Officer at the Scottish Government and Member of the Model of Care Polypharmacy Working Group In association with:

12.45 – 13.30

Lunch Symposium – Interactive case based discussion on managing patient’s anticoagulation – interactive voting system presenting cases and then using the latest available evidence to find a suitable solution* A series of interesting cases involving anticoagulation whereby the audience can vote using an interactive voting system and debating the latest evidence to find a suitable solution. Helen Williams MRPharmS PGDip(Cardiol) Ipresc, Consultant Pharmacist for Cardiology, Lambeth & Southwark CCG, London and Sotiris Antoniou RPS MSc DipMgt IPresc, Consultant Pharmacist, Cardiovascular Medicine, Barts Health NHS Trust Delivered by:

Delivered by: Inhaler technique Research shows that many people prescribed inhalers are unable to use them probably. It is also 15.00 – known that many healthcare professions also do not know the optimum technique for inhalers – Do 15.45 you? In this session Anna will provide an overview on the correct way to use and teach people how to use inhalers. Learn the 7 steps to inhaler success! Dr Anna Murphy MRPharmS (IP) Dpharm, Consultant Respiratory Pharmacist, Cardio-respiratory Directorate, University Hospitals of Leicester NHS Trust

Sponsored by:

14.00 – 14.45

Inhaler technique - identifying problems and proposing solutions This presentation will consider the consequences of poor inhaler technique. The workshop will demonstrate the scale of the problem and the impacts on patient’s health and the NHS. We will propose quality assured and sustainable solutions to the problem and outline how targeted inhaler training for healthcare professionals can support respiratory patients to optimise their inhaler technique. We will also look at evidence from an inhaler technique project that demonstrates improved outcomes for respiratory patients. Margaret Allan BPharm(Hons), Acting Director, Wales Centre for Professional Pharmacy Education (WCPPE) and Sarah Ridgway Green MRPharmS MBA, Regional Manager for South East Coast, CPPE

Consultation skills – improving your performance Effective consultations with patients lie at the heart of delivering patient-centred care however achieving an effective patient-centred consultation in practice can present challenges. Health Education England has identified enhancing communication and consultation skills as a priority within the medicines optimisation agenda. This has led to the development of the new practice 15.15 – standards for consultation skills which set out the minimum standard of knowledge, skills and 16.00 behaviours expected of all pharmacy professionals. This session introduces you to the new standards and the Consultation Skills for Pharmacy Practice website which offers a six step pathway to developing practice. Chris Cutts, Director, CPPE and Lesley Grimes MRPharmS, Senior Pharmacist, Learning Development, CPPE, University of Manchester Optimising the use of medicines in older people during transfer of care • Medicines related risks associated with older people during transfer of care, the impact on patient outcomes and wider implications for the NHS • Use a representative admission-discharge pathway for an older person to identify medicines related risks at various handover points • Patient centred 16.15 – strategies to mitigate risks and improve outcomes • Priority areas for pharmacy to lead medicines 17.00 optimisation. Lelly Oboh MPharmS Ipresc PGDip Clin Pharm, Consultant Pharmacist, Care of Older People, Guys & St Thomas NHS Trust Community Health Services and East & South East NHS Specialist Pharmacy Services

*This Congress is supported by educational grants from various companies who have not influenced the meeting content or the choice of speakers however those sessions marked with an asterisk (*) are being delivered with input from the sponsoring company. Please note: This programme is subject to change as speakers & session titles are confirmed - this is a working document.

Refresher

Advanced

Register NOW at www.pharmacycongress.co.uk

Free Lunch


www.pharmacycongress.co.uk

CLINICAL THEATRE 1

ey

Andrea Devan

e Date Heather Leak

Celia Feetam

FRIDAY 25TH APRIL

Sponsored by:

s

Helen William

w Man-Chie Cho

Neil Tickner

SATURDAY 26TH APRIL

Upskilling to deal with children and their medicines Medicines use in children is becoming increasingly complex and pharmacists play a central role in ensuring patients receive appropriate formulations, doses and advice. Neil will offer a practical guide to managing medicines in children to reduce the stress of screening paediatric prescriptions and 10.00 – upskill your knowledge base of paediatric medicines use. This is an informative presentation for the 10.45 practical management of medicines in children, for both community and hospital pharmacists alike. Neil Tickner MRPharmS PG Dip Clin Pharm, Lead Pharmacist Paediatrics, Imperial College Healthcare NHS Trust

11.15 – 12.00

Targeted therapies in Haemato-Oncology; beyond imatinib and rituximab This session will look at targeted therapies currently used in the treatment of multiple myeloma, leukaemia and lymphoma. New developments in targeted therapy used in haemato-oncology will also be reviewed, including the use of new subcutaneous formulations. The discussion will include how these new agents and new formulations fit into treatment pathways of these diseases. Man-Chie Chow MSc PGDipClinPharm MRPharmS, Lead Pharmacist Haemato-Oncology, The Royal Surrey County Hospital NHS Foundation Trust In association with:

In association with: Top ten things you need to know about HIV Antiretroviral (ARV) therapy has transformed HIV from a death sentence into a chronic, manageable disease. Although people with HIV may have a normal life expectancy, there is still considerable morbidity, and pharmacists play a key role in reducing this. Providing home testing kits, managing drug interactions and helping reduce mother to child transmission of HIV are a few of the aspects of 11.30 – HIV care where pharmacy has a positive impact. Within the next decade more than half the people 12.15 living with HIV will be over the age of 50, so issues of co-morbidities, polypharmacy, adverse effects and drug interactions will also become more prominent. Heather Leake Date MSc MRPharmS IPresc, Consultant Pharmacist HIV/Sexual Health and Honorary Senior Lecturer, Brighton & Sussex University Hospitals NHS Trust In association with:

Sponsored by:

Lunch symposium – Medicines optimisation in schizophrenia: balancing the need to consider mental and physical health* Medicines optimisation is a pathway to improving long term outcomes. Pharmacists can play a vital role in supporting patients with severe mental illness (SMI) by facilitating choice, supporting recovery and promoting evidence based guidelines. People with psychosis face 15 – 20 year 13.00 – premature mortality. New NICE guidance and the national CQUIN focus on improving the physical health of those with schizophrenia. The SMI population makes up 5% of the total population 13.45 but accounts for 18% of total deaths. We must look beyond short term economic gains towards maintaining and improving the long term physical health as well as the mental health of patients. Celia Feetam BPharm(Hons) MSc MRPharmS FCMHP, Postgraduate Tutor, Aston University Birmingham Delivered by: A beginner’s guide to renal transplantation This presentation will provide some general facts on renal transplantation and explain why medicines optimisation is a key role for the pharmacist in the management of these patients during their transplant care pathway. In addition an overview will be shared on the immunosuppressive 15.00 – strategies commonly used and what pitfalls to look out for and what actions to take when providing pharmaceutical care to these patients on a general medical/surgical ward. 15.45 Andrea Devaney BPharm MRPharmS (IPresc) FFRPS DipClinPharm MSc, Consultant Pharmacist – Transplantation and Renal Services, Oxford University Hospitals NHS Trusts In association with:

16.15 – 17.00

9

Lunch symposium: HER-2 positive breast cancer: innovation driven benefits* Dr Mark Verrill, Head of the Department of Medical Oncology and the Deputy 12.45 – Lead Clinician for breast cancer, North of England Cancer Network; Member of the 13.30 National Cancer Research Institute (NCRI) Breast Clinical Studies Group Delivered by: A new era in the world of hepatitis C treatment – exciting times but what challenges do we face? The world of hepatitis C treatment is undergoing a revolution of sorts. We are now faced with complex drug regimens which need to be specifically tailored to suit patient specifics so as to obtain 14.00 – the best results. Pharmacists will need to have a thorough understanding of the evidence base and mechanisms of these new drugs. The session will detail how hepatitis treatment has evolved and 14.45 will give a synopsis of the current and future drugs which will come available. It will also outline the challenges that these treatments will bring and how pharmacists are well placed to deal with these. Ailsing Considine MPharm, Team Leader Liver Pharmacy Team, Kings College Hospital An introduction to interstitial lung disease (ILD) The term Interstitial Lung Disease (ILD) encompasses a wide, and diverse, range of conditions and the management of the different types present numerous opportunities for healthcare professionals 15.15 – to have meaningful and rewarding input into patient care and service development. The presentation 16.00 will provide an introduction and overview to the ILD’s for non-specialist and include the approaches to managing two of the more common types; pulmonary sarcoidosis and idiopathic pulmonary fibrosis (IPF). Philip Lloyd Mayers MRPharmS Clin Dip Pharm, ILD, North Bristol NHS Trust and Respiratory Pharmacist Bristol Interstitial Lung Disease Service 16.15 – 17.00

Hyperlipidaemia management Helen Williams MRPharmS PGDip(Cardiol) Ipresc, Consultant Pharmacist for Cardiovascular Disease, South London Cardiac and Stroke Network

UK Renal Pharmacy Group

Care homes and supporting safer medicines Overview of the use of medicines in care homes including a summary of recent evidence and guidance • Risks associated with medicines handling processes, polypharmacy, falls, adverse drug events and non adherence • Problems with training, staff competencies, communication and co-ordination of care • Current gaps in providing and commissioning medicines related services to care homes • Priority areas and strategies to reduce risks, optimise medicines use and improve outcomes • Identifying the important role that pharmacists can play. Lelly Oboh MPharmS Ipresc PGDip Clin Pharm, Consultant Pharmacist, Care of Older People, Guys & St Thomas Community Health Services and East and South East NHS Specialist Pharmacy Services

Drug treatment of retinal eye disease In the last few years the drug treatment of sight threatening retinal diseases has changed beyond all recognition. It has moved on from vitamin supplements with questionable efficacy to biologicals and high tech delivery systems and measurable outcomes. This session will briefly cover retinal diseases that currently have NICE approved treatments (age related and pathological myopic 17.15 – macular degeneration, diabetic macular oedema, retinal vein occlusion and vitreomacular traction). 18.00 Those drugs covered by the NICE guidelines, their place in therapy and potential implementation problems in practice will be discussed. Elaine Mann BSc (Hons) Clinical Pharmacy Diploma MRPharmS, Ophthalmic Pharmacist, Leeds Teaching Hospitals NHS Trust In association with:

UK Ophthalmic Pharmacy Group

*This Congress is supported by educational grants from various companies who have not influenced the meeting content or the choice of speakers however those sessions marked with an asterisk (*) are being delivered with input from the sponsoring company. Please note: This programme is subject to change as speakers & session titles are confirmed - this is a working document.

Refresher

Advanced

Register NOW at www.pharmacycongress.co.uk

Free Lunch


10

www.pharmacycongress.co.uk

Keynote Theatre

S5

S11

S12

PCCPN

RPS

S9

S4 CMHP

S3

BOPA

S6 S10 S5 OPG PCPA

S8

S2 A60 The organisers have created a clinical industry forum that gives pharmacy professionals the opportunity to network, pick up new information in their specialist areas and refresh their knowledge of other areas. The whole of the pharmacy profession needs to move towards clinical pharmacy and I believe this show will go from strength to strength. David Branford, Chief Hospital Pharmacist, Derbyshire Mental Health NHS Trust This is the first event to get all the disparate bits of pharmacy under one room. Even the big societies haven’t been able to do that. This is a forum where people come to meet others. I’m constantly being collared by people, which is what I’m here for. The show attracts people from all sectors so you hear viewpoints from across the board and that’s very important for pharmacy. Duncan Petty, PCPA Chairman and Practice Pharmacist, Bradford

Clinical 1 Theatre Sponsored by:

B60

Torbay Pharmaceuticals

Special Products

A55

Seats - 500 C60 C65 Huddersfield Pharmacy Specials

S1

NPPG

Seats - 400 E60 E65

D60

Truven Health

Royal Free Specials

Helapet

F60

F67 H60

F65

Shoreline

IMI BJMP

HappyFeet

NHS Protect

C55

B55

A50 Sterling Pharmaceuticals

NHS Manufacturing

NEW

A42

D40

Leaders Forum

Network Packaging

Grünenthal

Northwick Preston Park and Pharmaceuticals St Mark’s Hospital

D45

E45

Kora Healthcare

Actavis

Supported by:

H50

F53

Moorfields

Aguettant

CoAcS

H45

F48

NuPharm

Pharmacist Support

Roche Products

H40

F40

E40

Biogen Idec

F50

F45

B Braun

D43

Veenstra

AstraZeneca

E52

E50

D52

H55

F55

hameln pharmaceticals

Bayer

HCA Hospitals

Avantec Sintek

E55

D50

Teva

A43

D55

Horizon SP

C50 Baxter

A45

C58

Added Pharma

B50

ITH Pharma

Durbin LEC

H35

A40

The IMC Group Ltd

B35

C35

Lundbeck

A35

Polar Thermal

Janssen

C30 Chiesi

D10

Labmed

D35

E35

IDIS

HD Medi

F36

H34

Pharmacy Medical

Abbott Sandoz Healthcare

E30

D30

B30

F30

Fagron

Pharma Nord

Wockhardt

H30

Mistura

Orion

A33

The Author's Licensing & Collecting Society B25

A25

C26

Army Medical B22 A20 Services Territorial Army PDA

A17

Pulse Pharmacy

A15

B20

Mediwell Systems

Bupa Home B15 B18 Healthcare St George's NHS B12 Trust CHS

B10

G24 H28

RIG IPS Medical Specials

Nova Labs City Sprint Healthcare

G23

F20

Café

Sponsored by:

C20

C15

D17

BD Medical ID Medical

Bristol-Myers Squibb / Pfizer

Willach

D19

Pharmarama

E15

Daiichi Sankyo

D13 Springer

E10

D12 Polarspeed

Abloy

G12 G15

F18

Aclardian HSCIC Ltd

Mylan

Quantum Pharmaceutical

G11 G18

3 Spirit Medical 6sqm

Innovation & Technology Forum

E14

G10

A Menarini

HOLD

NEW

A1

4

Guy’s and St Thomas’

B1 Labcold

ENTRANCE

D1

E1

SPEAKERS / PRESS OFFICE

F1

Gram

MEDA

ORGANISER’S OFFICE

G26

Deep T CPC 2015 Massag SALES OFFICE G28 Roche G20 Products Oncology Sensible Staffing

DX

C10 Sanofi

A10

C27

Lundbeck/ Otsuka

Mawdsleys

B21

F25

C25

QDEM

Fresenius Kabi

Barts Pharmaceuticals

Medisca

Seats - 150

Sponsored by:

S7 CPPE

UKRPG

Leo Pharma

Clinical Th

APTUK

HIVPA

Anton Paar

G1

MSD

3


www.pharmacycongress.co.uk

11

2014 CONGRESS LAYOUT

R E V The home of clinical pharmacy O 20 RS 1 IBITO The Exhibitors H X E

heatre

Leadership Theatre Seats - 200

NEWR FO14 20 H26 GPhC

Tissue ger

H20

Eastbourne Pharmaceuticals

H17

Parkinson's UK

H15 TEMAG Pharma

H10 T+R Derma

Medicines Optimisation Workshop

(round-table sessions) Sponsored by:

Seats - 250

A. Menarini Farmaceutica Internazionale UK SRL Abbott Healthcare Abloy UK Aclardian Specials Actavis UK Ltd Added Pharma Aguettant Anton Paar Army Medical Services - Territorial Army Association of Pharmacy Technicians UK (APTUK) AstraZeneca Avantec B Braun Medical Barts Pharmaceuticals Baxter Healthcare Bayer BD Medical Biogen Idec BMS/Pfizer British Journal of Medicines Procurement British Oncology Pharmacy Association (BOPA) Bupa Home Healthcare Cambridge Healthcare Supplies Ltd Centre for Pharmacy Postgraduate Education Chiesi City Sprint Healthcare CoAcs Ltd College of Mental Health Pharmacy (CMHP) Daiichi Sankyo UK Ltd Deep Tissue Massager Durbin DX Group Eastbourne Pharmaceuticals Fagron UK Ltd Fresenius Kabi General Pharmaceutical Council Gram Bioline Grünenthal Guy's and St. Thomas' NHS Foundation Trust Hameln Pharmaceuticals Happy Feet Merseyside HCA Hospitals HD Medi Health And Social Care Information Centre Helapet Ltd HIV Pharmacy Association (HIVPA) Horizon Strategic Partners Huddersfield Pharmacy Specials ID Medical Idis Ltd IMI Irish Medical Information IPS Specials ITH Pharma Janssen Kora Healthcare Labcold Ltd Labmed Recruitment Lec Medical Leo Pharma Lundbeck

E14 F30 E10 G12 D40 C55 H50 F1 A20 S8 F55 A45 E45 A25 B50 D55 C15 D43 C10 H60 S9 B15 B12 S1 C30 C25 F53 S4 D19 G26 H40 C20 H20 E35 B25 H26 E1 D52 A1 E55 F65 D50 D30 G15 E60 S3 C58 C60 D17 D35 F67 H28 E40 C35 D45 B1 D10 F40 C65 B35

Lundbeck/Otsuka Mawdsleys Meda Medisca Mediwell Systems Mistura Moorfields MSD Mylan Neonatal and Paediatric Pharmacists Group (NPPG) Network Packaging NHS Manufacturing NHS Protect Northwick Park and St Mark's Hospital Nova Laboratories NuPharm Laboratories Ophthalmic Pharmacy Group (OPG) Orion Pharma (UK) Ltd Parkinson's UK Pharma Nord Specials Pharmacist Support Pharmacy Medical Pharmarama International Ltd Polar Speed Distribution Polar Thermal Packaging Preston Pharmaceuticals Primary and Community Care Pharmacy Network (PCCPN) Primary Care Pharmacy Association (PCPA) Pulse Pharmacy Qdem Pharmaceuticals Quantum Aseptic Services and UL Medicines RIG Healthcare Recruit Ltd Roche Products Ltd - Oncology Roche Products Ltd - Rhematology Royal Free Specials Royal Pharmaceutical Society (RPS) Sandoz Ltd Sanofi Sensible Staffing Shoreline Medical Refridgeration Sintek Ltd Special Products Ltd Spirit Medical Springer St. George's Healthcare NHS Trust Sterling Pharmaceuticals T+R Derma Temag Pharma Teva UK Ltd The Authors’ Licensing & Collecting Society The IMC Group Ltd The Pharmacists' Defence Association Torbay Pharmaceuticals Truven Health Analytics UK Renal Pharmacy Group (UKRPG) Veenstra Willach Pharmacy Solutions Wockhardt

C27 B20 D1 A15 B21 B30 F50 G1 F18 S7 A42 B55 A55 E50 F25 F45 S6 H30 H17 H35 H45 H34 F20 D12 A35 E52 S5 S10 A17 C26 E15 G24 G28 F48 E65 S12 F36 B10 G20 F60 A43 A60 G11 D13 B18 A50 H10 H15 C50 A33 A40 B22 B60 D60 S2 H55 A10 E30


12

www.pharmacycongress.co.uk

INNOVATION & TECHNOLOGY FORUM FRIDAY 25TH APRIL

9.45 – 10.45

SATURDAY 26TH APRIL

Innovation Award Shortlist presentations (three) Superdrug HIV and Hepatitis C Pharmacy Support Service Tim Morgan, Pharmacy Manager, Superdrug Pharmacy, Newport Integrated care clinical pharmacists for frail older people in the community Lelly Oboh MPharmS Ipresc PGDip Clin Pharm, Consultant Pharmacist, Care of Older People, Guys & St Thomas NHS Trust Community Health Services and East & South East NHS Specialist Pharmacy Services Development of the Barnsley Pharmacist-led Inflammatory Bowel Disease and Autoimmune Hepatitis clinic in a General District Hospital Fernando Garcia Fuertes, IBD Pharmacist, Barnsley Hospital NHS Foundation Trust

Benchmarking and optimising medicines usage The need to compare is not just for insurance. NHS secondary care spend on drugs will be almost £7bn (2014 est) with a growth rate of 12% p.a seen over the last 4 years. Managing prescribing 11.00 – quality and costs are important challenges in today’s healthcare sector and achieving this requires high quality accessible information. The presentation shows how Define can be used to turn drug 11.45 use data into knowledge and improve efficiency within the use of medicines. No moustaches and no opera singing. Promise. Colin Richman BPharm (Hons) MRPharmS, Company Director, RX-Info Ltd

Sponsored by:

Ignite: Innovation

Innovation Award Shortlist presentations (three) A clinico-ethical framework for multidisciplinary review of medication in nursing homes Nisha Desai, Senior Clinical Pharmacist for Frail Elderly Services, Pharmacy Department, Northumbria Healthcare NHS Foundation Trust Pharmacists Writing Discharge Medication Prescriptions at King’s College 11.00 – Hospital (KCH) 12.00 Raliat Onatade, Deputy Director of Pharmacy, Clinical Services, King’s College Hospital NHS Trust Theatre Admissions Lounge (TAL) Pharmacy Team Nick Haddington, Lead Pharmacist Education and Training; Julia Nichols; Denise Reeves; Adegbayi Ukoha, Great Western Hospitals NHS Foundation Trust (Swindon)

Pharmacy Black Box Alberto Ortiz-Moya, Specialist Medicines Information Pharmacist, Humber NHS Foundation Trust

Sponsored by: Supporting aseptic compounding* To make it possible to provide personalised pharmaceutical care to patients, Industry needs to listen to its customers and work closely with prescribers, pharmacists and continue to develop a strategy of optimising and innovating pharmaceutical compounding. How can we help widen the therapeutic scope of the Prescriber and Compounding Pharmacist to offer bespoke pharmaceutical solutions and in particular the Aseptic 12.45 – Compounder, who needs leading-edge equipment with minimum validation requirements 13.30 and innovative accessories to help reduce time-consuming repetitive manual operations and the opportunity for human error. How can we make life easier and more efficient for the Aseptic Compounder and ultimately much better and safer for the Patient. Jonathan Fawdry MRPharmS, General Manager, Fagron UK Ltd

Clinical trials – corporate partner joins hospital pharmacy Anish Patel, Specialist Pharmacist & Clinical Trials Lead, Birmingham Women’s NHS Foundation Trust LEICESTERSHIRE PHYSICAL HEALTH REGISTER (LPHR) – an electronic database for monitoring the physical health parameters for patients on psychotropic medication - a pilot project Dolly Sud, Specialist Mental Health Pharmacist, Leicester Partnership NHS Trust Medicines Management Team with Intermediate Care Naomi Fleming, Antibiotic Pharmacist, Milton Keynes Community Health Services and Susan Marshall, Medicines Management Technician, Milton Keynes Community Health Services 14.15 – 15.15 Implementation of a clinical pharmacy and medication dispensing service in a chemotherapy day treatment unit Professor Nicola Stoner, Cancer Consultant Pharmacist, Oxford Cancer and Haematology Centre & Oxford Cancer Research Centre, Churchill Hospital, Oxford University Hospitals NHS Trust A study to determine the current practice of health care professionals when reviewing and prescribing medication in women who are pregnant or of childbearing potential Samuel Wood, Clinical Pharmacist, Central Manchester University Hospitals NHS Foundation Trust

Delivered by: A patient’s journey: codes, horrors and successes A simple journey through the hospital experience, showing the interaction points with technology. A journey mapped out in text and images, which is then built upon to demonstrate the 15.00 – improvements which can be achieved by harnessing the power of technology. 15.45 Judie Finesilver BSc(Hons) MRPharmS, eBusiness, Commercial Medicines Unit, Department of Health Summary Care Records The presentation will explain what Summary Care Records (SCR) are, and will illustrate how they are being used by hospital pharmacies across England to support the medicines reconciliation process. The programme will share high level benefits and audit data from 16.00 – a number of hospital trusts, together with details of the support that your organisations can call upon when implementing SCR. Join the hospital pharmacies now using SCRs to 16.45 improve patient care at your organisation. Mohammed Hussain MRPharmS, Pharmacy Lead, Summary Care Record Programme, Health and Social Care Information Centre and Chair, Pharmacy Local Professional Network, West Yorkshire, NHS England Managing homecare services in secondary care 17.00 – George Gannon, Pharmacy Operations Manager, 17.45 Pharmacy Business & Distribution Centre, UCL Hospital Trust

Pilot: Mental Health Medicines Review Service Tsana Rawson, Lead Clinical Pharmacist, City and Hackney Centre for Mental Health; East London Foundation Trust (ELFT) Measuring the osmolality of drugs given to preterm infants in the UK Zoe Lansdowne, Neonatal Pharmacist Social Media Why use social media? This is a practical and interactive session examining the value of social media for networking, engagement and communication. The use of social media channels is now an essential part of modern healthcare. Professionals need to have a presence if they are to keep upto-date with what others, including service users, are saying and debating. The presentation session 15.30 – will look at: The various platforms available and the differences between them. • Social media use 16.15 by other professionals • Social Media Highway • Tricks and pitfalls for new users and organisations • How to amplify your message • How to build your networks • Using networks to deliver change and improve patient care. Mohammed Hussain MRPharmS, Pharmacy Lead, Summary Care Record Programme, Health and Social Care Information Centre and Chair, Pharmacy Local Professional Network, West Yorkshire, NHS England

LEADER’S FORUM (by invitation only) FRIDAY 25TH APRIL Continuing Fitness to Practise: Gathering patient feedback on 10.15 – hospital pharmacists - what are the challenges and what are the solutions? 10.45 Damian Day, Head of Education, GPhC 11.15 – An update from NHS England 11.45 Clare Howard, Deputy Chief Pharmaceutical Officer 12.45 – 13.30

Tackling winter pressures* Session led by Bupa Home Healthcare

Francis - one year one Catherine Duggan PhD FRPharmS, Director of Professional Development and Support, Royal Pharmaceutical Society How can APTUK support individuals and managers to maximise 16.00 – the opportunities of professional framework developments? Tess Fenn, Vice President, 16.30 Association of Pharmacy Technicians (UK) How BOPA is undertaking joint working with the RPS 17.00 – Helen Flint, Clinical Services Manager, Clatterbridge Cancer 17.30 Centre and Treasurer / Vice Chair, BOPA 15.00 – 15.30

Sponsored by:

SATURDAY 26TH APRIL How NICE medicines and prescribing centre can help your organisation with medicines optimisation 11.30 – Michelle Liddy, Medicines Education, Regional Technical Adviser (London) Medicines and Prescribing Centre and Zoe Girdis, 12.00 Regional Technical Adviser for the South and Channel Islands, NICE - National Institute for Health and Care Excellence 14.30 – 15.00

Linking medicines optimisation with parity of esteem recommendations Jennifer Southern, CMHP, Senior Clinical Pharmacist for Mental Health, Cheshire and Wirral Partnership NHS Foundation Trust

Reliable care for children in the new NHS: Focus on the strategic context for reliable care - standardisation, risk, governance and how we might overcoming the barriers to it Adam Sutherland MRPharmS, Senior Clinical Pharmacist, 15.30 – Paediatric Critical Care & Metabolic Medicine, Central 16.00 Manchester University Hospitals NHS Foundation Trust and Farrah Kahn, Head of Medicines Information and Paediatric Formulary, Barts Health NHS Trust

*This Congress is supported by educational grants from various companies who have not influenced the meeting content or the choice of speakers however those sessions marked with an asterisk (*) are being delivered with input from the sponsoring company. Please note: This programme is subject to change as speakers & session titles are confirmed - this is a working document.

Refresher

Advanced

Register NOW at www.pharmacycongress.co.uk

Free Lunch


www.pharmacycongress.co.uk

Have you considered working for a private hospital before? patient load. Within HCA Hospitals we cover a number of acute specialities including oncology, paediatrics (including PICU & NICU), haematology, orthopaedics to name a few. Working across these specialities, combined with great training, development and leadership, really allows our pharmacy teams to develop their skills and knowledge and build a fantastic career with us.

Neither had a number of our pharmacy team members, but now they have made the move they haven’t looked back. Ashita Tailor (Pharmacy Manager at The Harley Street Clinic) says “before I was approached to work for HCA Hospitals, I had no idea about careers within a private setting. Since joining the team I’ve been able to do further training and have spent time developing my team, which is really important across the whole of the HCA Hospitals group. At The Harley Street Clinic my team work closely with consultants and the multidisciplinary team to ensure we offer the best service possible across both adult and paediatric specialities”. Not only can private hospitals offer great access to cutting edge technology and working with world renowned Consultants, they also give access to working with a varied, acute

HCA International is London’s largest private hospital group with 6 world-class hospitals across the capital, including The Harley Street Clinic, The Lister Hospital, London Bridge Hospital, The Portland Hospital, The Princess Grace Hospital and The Wellington Hospital. We are also growing our joint collaborations with the NHS, with private facilities at UCH, Queen’s in Romford and The Christie in Manchester. Our primary purpose is to provide exceptional care delivered with compassion and kindness, using state-of-theart technology, operated by dedicated teams. We are committed to continual professional development for our Pharmacy Teams and support a wide variety of courses and qualifications. This ranges from NVQs to LPET courses, certificates and diplomas with a variety of approved university partners. We ensure our teams have everything they need to be able to grow and develop within their roles and within the wider HCA Group, allowing them both the knowledge and progression to develop their career.

If you’re looking to grow and develop your career within a supportive company which puts you at the leading edge of the healthcare industry, be sure to visit www.hcacareers.co.uk to find out more or apply. VISIT US AT STAND D50

13

THE “SPECIAL” PROBLEM With the shift toward caring for patients in primary care problems can occur due to lack of specialised knowledge coupled with reluctance to question experts. An overdose of ciprofloxacin for a child on an FP10HNC was dispensed without question as it was assumed that the specialist hospital doctor was correct. This is even more of a risk in a niche specialism like ophthalmology. Analysis of primary care prescription data has thrown up such examples as dexamethasone 1% eye drops, sodium chloride 0.5% eye drops acetylcysteine 0.5% eye drops and pilocapine 0.4%. These have all been made by special manufacturing units at significant cost to the NHS. Irrespective of the cost is the patient going to benefit? If the patient has corneal oedema a hypertonic 5% solution of sodium chloride not a 0.5% hypotonic solution is required. A 0.4% pilocarpine solution is unlikely to control a patient’s glaucoma while dexamethasone 1% is likely to cause a significant rise in intra ocular pressure. Primary care data from the first nine months of 2013 (all subsequent financial information is for the same time period) indicates that £625k was spent on preservative free hypromellose 0.3%. There are three unit dose medicines/devices on the market Hydromoor®, Lumecare® and Tears Naturale®, (four if Artelac® 0.32% is included) and one multi-dose preservative free product, Tear-Lac®, in a COMOD device. There are 54 ocular lubricant preparations listed in Part IXA of the drug tariff in addition to the licensed medicines available. So why are hypromellose 0.25% preservative free, at a cost of £21K, and sodium chloride 0.9%, an ineffective lubricant (£30K), being prescribed and dispensed in traditional multi-dose bottles which are easily contaminated? The top five items in cost are all available as licensed medicines or devices, hypromellose 0.3% preservative free (PF), Dexamethasone 0.1% PF (£107K), Sodium cromoglicate 2% PF (£91k), Pilocarpine 2% PF (£68k) and prednisolone 0.5% PF (28K). The consensus is that a licensed product should be supplied in preference to a special so why is this not being followed. There is always the occasional patient who is an exception but it seems improbable that there are so many. To improve patient safety, and secondarily to reduce cost, the UK Ophthalmic Pharmacy Group and the Royal College of Ophthalmologists have produced guidance on what they consider may be safely prescribed and dispensed in primary care. It lists potential errors to query with the original prescriber and makes suggestions of licensed alternatives. This will be launched shortly and should hopefully resolve some of the issues of the “special” problem.

COME SEE US

BOOTH A15

20 years of innovation and quality In only 20 years, MEDISCA has developed a solid reputation as an innovative and entrepreneurial company in the pharmaceutical compounding industry. MEDISCA’s mission is to provide the compounding industry with the highest quality active pharmaceutical ingredients (APIs), including narcotics and controlled substances, bases, excipients, equipment and devices at highly competitive prices coupled with exceptional service. We are dedicated to providing the highest quality products and supplies, unparalleled service and competitive pricing to our clients located around the world. We share a common goal: to succeed in what we do from both a professional and business perspective. Together, we can maintain and improve the integrity, quality and diversity of pharmacological care. The strength of our alliance will serve to consolidate this task – simply envision yourself as part of the MEDISCA mission! MEDISCA.COM

Education is the foundation of our business MEDISCA NETWORK, our independent educational arm and trusted partner, offers a comprehensive portfolio of compounding training activities through the use of ACPE-accredited providers. The broad range of training activities are held in multiple venues across North America for pharmacists, pharmacy technicians and allied health professionals. MEDISCA NETWORK also imparts expertise in facility design, allowing you to build a compliant environment for your practice, thus instilling quality and confidence in your patients. Moreover, MEDISCA NETWORK provides Technical Support Services geared toward the practice of pharmacy compounding, enabling customized pharmaceutical care. We offer you over 5,000 formulas, customized formula support, standard operating procedures, proactive practice management modules, and consultation services that meet the demands of today’s pharmacy compounding community. MEDISCA.NET

TO Find OuT mOre call us aT : 001.514.333.7811


14

www.pharmacycongress.co.uk

The Clinical Pharmacy Congress is organised by CloserStill Media Healthcare Limited George House, Coventry Business Park, Herald Avenue, Coventry, CV5 6UB. Tel: 02476 719690

Matthew Butler, Congress Director m.butler@closerstillmedia.com Laura Shapiro, Congress Manager l.shapiro@closerstillmedia.com Lucy Pitt, Marketing Director l.pitt@closerstillmedia.com Ellie Cave, Marketing Executive e.cave@closerstillmedia.com Penny Law, Operations Manager p.law@closerstillmedia.com Kate Jackson, Conference Manager k.jackson@closerstillmedia.com

WHEN & WHERE... ExCeL London Friday 25th April 2014: 08.30 – 18.00 (networking drinks at 18.00 – 19.30) Saturday 26th April 2014: 08.30 – 17.00

Are you a Pharmacy Technician? If you answered yes to this question and you are reading this article, it’s very likely that you are already committed to professional excellence. The Clinical Pharmacy Congress (CPC) is one of the best opportunities in the year to meet like-minded people and find out what is going on for pharmacy professionals. So now, another question, sorry to tax your brain, but we know that people coming to CPC are always looking for ways to improve. Have you heard of the Association of Pharmacy Technicians (UK) (APTUK)? We know that many of you will answer yes and, if that is the case, then we would love to see you at Stand S8 at CPC. When visiting us you can say hello to some of our National Officers and find out what’s happening. It’s also an opportunity for you to tell us what you think about our work and to make suggestions about services that you might like us to provide. Whilst we love to see people who are already members, we are also very keen to meet people who have never heard of us or those who have, but are still not members. You will all be given a very warm welcome, you will learn more about who we are and what we do and, if we get it right, you may even decide to join!

To help you make a decision about coming to visit us, we felt it would be useful to explain what we do. APTUK is the ‘professional leadership’ body for pharmacy technicians and is run by 12 National Officers who are all pharmacy technician volunteers. We are passionate about our work on behalf of our members and this demonstrated through our strapline ‘Promoting excellence for pharmacy technicians and safety for patients’. We are the only organisation specifically representing pharmacy technicians and we are the ‘voice’ for the profession. We are engaged at all levels of pharmacy development allowing us to influence on behalf of our members. We provide networking and development opportunities and keep members up to date through the publication of a quarterly journal which is sent out to all members. We believe that being a member of APTUK marks you out as striving to be professionally the best that you can. Curious? Want to know more? Then come and see us on Stand S8 at CPC and find out more about us and our annual conference taking place 13th and 14th June. VISIT US AT STAND S8

How to get there: The Clinical Pharmacy Congress is held at the ExCeL London, which is located 10 minutes from Canary Wharf in the heart of London’s Royal Docks. There is easy access to the venue via road, rail and air. Please note that, while the Congress will be taking place in halls N3/4/5, you will need to enter the London ExCeL via hall N3 (alight at Customs House, on the DLR). If you are arriving on foot, please do keep this in mind when you arrive on the main boulevard. For more information please visit: www.pharmacycongress.co.uk/travel-accommodation

Visit us at stand A10

robotic systems The right prescription for every pharmacy.

Modular design for ergonomic use. With CONSIS robotic and FAMA shelving systems for hospital pharmacies. Bigger and better medicine storage for inpatient, outpatient and ward dispensing. Ergonomically engineered for quick, easy access and maximum storage capacity, Willach’s CONSIS robotic and FAMA shelving systems are designed especially for hospital pharmacies. Our extensive research has enabled us to create medicine storage that's extraordinarily efficient. And because it’s modular, we can tailor your solution to meet your exact needs in any inpatient, outpatient or ward dispensing environment.

www.willach.com


www.pharmacycongress.co.uk

Hospital standards – What’s new for 2014? The RPS reports on the implications for pharmacists at how colleagues have been taking on the quality challenge. All our resources that support the implementation of the hospital standards can be found on the RPS website (www. rpharms.com/hospitalstandards) along with links to other helpful sources such as the recent resource from East and South East England Specialist Pharmacy Services that links our hospital standards with their support tools. Ruth Wakeman, the Society’s Head of Professional Support says: “It is an exciting year for the hospital standards, one we hope will see them further embedded in practice and confirm both within and outside the profession their place in helping to drive the ongoing improvement of pharmacy services.”

Since July 2012 when the Society published the RPS standards for pharmacy services in acute, mental health, private and community service providers, the profession has been active in bringing them to life locally. Last year 35 sites from across Great Britain used the standards to review their services and develop action plans in line with the 10 hospital standards. The experiences of the sites are shared in a report and we would encourage anyone who is interested in improving the quality of their pharmacy services to take a look

With the publication of the Francis and Berwick reports last year the focus on quality is rightly centre stage for all professions. One of the first things that we will be doing in 2014 is refreshing the hospital standards to ensure that they are consistent with the ethos of the reports and using the opportunity to reaffirm our commitment to helping the profession develop quality pharmacy services. A small advisory group will be helping us work though the standards refresh during the next few months. Two other priorities we will be taking forward later this year are working to find solutions to improve delayed or missed doses of medicines in hospitals. We hope to work with colleagues from the Royal College of Nursing to find ways that the two professions can work together to find solutions to some of the problems professionals face on a day-to-day basis. Last but by no means least, toward the end of the year we will be starting on a piece of work that will look at best practice in patient engagement to determine how best we can measure patient experience of hospital services.

15

A refreshingly different approach to Allied Healthcare recruitment ID Medical is the UK’s leading multi-discipline medical recruiter with its AHP/HSS division dedicated team servicing every specialty in Allied Healthcare.

Visit us at stand D17 Register with us and find out first-hand why we’re the fastest growing AHP/HSS recruiter in the UK

WWW.ID-MEDICAL.COM T: 01908 552 283 E: ahp@id-medical.com /IDMedical uk.linkedin.com/in/idmedicalahp

PART OF THE


16

www.pharmacycongress.co.uk

Added Pharma is a flexible organization that delivers medical products and solutions for hospital pharmacies and commercial compounding companies. In these segments there’s a high demand for medical solutions and professionals with a pharmaceutical background. This is where Added Pharma excel. Our standard assortment is in the following product ranges: Disinfectants for hands, skin, and surfaces Dermatics Vitamins and minerals Compounding equipment Consumables Semi-finished products Medicines Added Pharma distinguishes itself by providing practical solutions and advice in the field of aseptic compounding. Our offices in Belgium, Germany, United Kingdom, and the Netherlands offer products throughout Europe. Added Pharma is GDP certified and works with GMP certified suppliers.

The Clinical Pharmacy Congress is RPS Accredited CloserStill Media and the Royal Pharmaceutical Society (RPS) are delighted to confirm that with a month to go and for the second consecutive year, the Clinical Pharmacy Congress (CPC) 2014 has been accredited by the RPS. RPS accreditation involves a rigorous process of quality assurance against agreed RPS accreditation standards. By successfully achieving RPS accreditation the organizers of CPC have demonstrated the event meets recognised RPS standards for quality and content.

VISIT US ON STAND C55

RPS accreditation ensures that you can be assured that the sessions and presentations at this conference will:  Contribute to your Continuing Professional Development (CPD)

pharmacycongress.co.uk April 25th – 26th 2014 ExCeL London

 Support you with your wider professional development, including professional development as part of your RPS Faculty portfolio  Contribute to supporting you with delivering excellent pharmacy practice and patient care The Royal Pharmaceutical Society is the dedicated professional body for pharmacists in England, Scotland and Wales. Accreditation with the RPS means that the event complies with the RPS Accreditation Standards and Criteria and that participation, together with effective evaluation, will enable visitors to gain skills, knowledge and attributes for their professional development. This year’s Congress, which will be held on April 25-26, 2014, ExCel, London, is already set to offer leading clinical pharmacists and opinion leaders in clinical pharmacy an exciting programme of education, training and information. Each year the Congress exceeds expectations and builds on previous successes and the 2014 show will be no exception.

Are you working within the Pharmacy sector and looking for a new opportunity? Rig Healthcare has a dedicated Pharmacy team who have been placing professionals since 2003 within NHS, Private and HM Prison settings. As medical recruitment market leaders we are best placed to offer you a great variety of roles to suit your skills and experience.

You will benefit from: • Dedicated consultants to help you find the right job and give you in-depth market advice • Assistance through the UK working requirements and compliance procedures • Negotiating on your behalf to get you the most competitive rate possible • First option of jobs from over 150 NHS and preferred clients • Excellent referral scheme of up to £250* • Tailored CV and interview advice • CPD loyalty scheme*

Already, the 2014 Congress is poised to deliver over 72 lectures and more than 54 hours of accredited CPD. With just under one month to go to the Congress, this accreditation provides a huge boost to the education programme already being planned in conjunction with a range of leading education partners including the Centre for Postgraduate Pharmacy Education (CPPE). The 2014 Congress will also see the first ever ‘Best of Clinical Pharmacy Awards’, which will celebrate and acknowledge outstanding individuals and teams within the pharmacy profession today. And, with over 120 exhibitors already booked to attend, and an anticipated audience of over 2,000 clinical pharmacy professionals, the Clinical Pharmacy Congress is clinical pharmacy’s best opportunity to meet, network, and share the expertise and insight of pharmacy’s leading players – all under one roof. Praising the 2013 Congress for its vital role in practice-sharing and learning development, England’s Chief Pharmaceutical Officer Dr Keith Ridge said: “This show is the ideal place for professionals to network, interact and discuss what the future might hold. There are other conferences around, but nothing quite like this one. It’s an important event.” Clinical Pharmacy Congress Director Matthew Butler said: “We are delighted to receive accreditation by the RPS. The RPS has positioned itself as the place for pharmacists to go to advance their professional practice. These aims resonate exactly with the objectives of the Clinical Pharmacy Congress, and we look forward to helping pharmacists exceed their aspirations and ambitions for clinical practice development again at the 2014 show.” If you don’t want to miss out on this once-a-year event – register now - by visiting:

For more information and latest vacancies visit: www.righealthcare.co.uk or contact us: +441423 790115 Email: info@righealthcare.co.uk

(T&C apply)

www.pharmacycongress.co.uk or by contacting: Ellie Cave, Marketing Executive Tel: 02476 719692 or Email: e.cave@closerstillmedia.com


www.pharmacycongress.co.uk

Win a weekend in Paris HIGH QUALITY PATIENT INFORMATION LEAFLETS • ALL of a patients medication summarised in electronic format • Can be printed out so patients have a hard copy to take away • Can be saved electronically and filed to a clinical record • Contains clear, consistent, up-to-date drug information

A HARD COPY OF WHAT YOU’D SAY TO A PATIENT Paragraphs containing less than 200 words including: • The medication name(s) • Any administration advice and warnings • Easy to read format and written in plain English • Main uses and other uses (licensed and unlicensed) • The main side effects and side effects to worry about

Collect a postcard in the registration area upon entering The Clinical Pharmacy Congress to be in with chance of winning this fantastic prize. Then visit the named exhibitors during your time at The Congress and answer a short question about their products and services to receive a stamp. Once completed, all correctly answered cards will be entered into a prize draw to win a Weekend Break for two in Paris. (terms and conditions apply). The lucky winner last year was Alexandra Cain, an Advanced Specialist Pharmacist at Central and North West London NHS Foundation Trust (CNWL). Below she tells us her experience at The Congress: “Attending the Clinical Pharmacy Congress was a brilliant opportunity to learn about current trends, not only in pharmacy but the wider healthcare economy. The revision sessions on cardiology were also very useful, as we all get a little rusty after a while, especially those of us who work in specialist areas such as mental health! It also meant the chance to catch up with old colleagues, and network with pharmacists and technicians from different organisations, contacts I’ll hopefully maintain for some time.

AIMS TO IMPROVE ADHERENCE An easy way to produce patient information leaflets that are: • Individualised to each and every patient • On-line, available 24/7, accessible by any staff • Organisational, trust or service branded throughout • High quality drug information written by clinical experts

Annual Subscription Available, To find out more contact us:

Email: sales@misturainformatics.org Office: 01670 528451 Fax: 01670 528440 A Route to Adherence - ‘Clearly Quite Clever’ www.misturainformatics.org

Taking part in the Paris competition meant I visited stalls that I may otherwise not have, because they weren’t related to my daily practice. Learning about some of the technological innovations in other areas of pharmacy was really interesting. Winning the trip was really the icing on the cake at the end of a fantastic day!”

Five companies who are taking part in this year’s competition are: VISIT US ON STAND E60 VISIT US ON STAND E45 VISIT US ON STAND F1 VISIT US ON STAND E55 VISIT US ON STAND G11

EASING THE PRESSURE – IV ANTIBIOTICS AT HOME Bupa’s OPAT service can help you free up capacity, support early discharge and provide a quality, nurse-led service in the most appropriate setting. Talk to us on stand B15

17


18

www.pharmacycongress.co.uk

Industry-led symposia 13:00 - 13:45 Clinical Theatre 1

SATURDAY 26TH APRIL

Medicines optimisation in schizophrenia: balancing the need to consider mental and physical health

10:00 - 10:45 Keynote

Celia Feetam BPharm(Hons) MSc MRPharmS FCMHP,

Postgraduate Tutor, Aston University Birmingham

FRIDAY 25TH APRIL 11:30 - 12:15 Clinical Theatre Mission remission: Access, evidence and immunology – is remission achievable for rheumatoid arthritis patients when methotrexate is no longer appropriate? Caron Underhill, Biologics Pharmacist, University Hospital Southampton NHS Trust and Professor Ernest Choy, Head of Rheumatology and Translational Research Institute of Infection and Immunity, Cardiff University School of Medicine

Medicines optimisation is a pathway to improving long term outcomes. Pharmacists can play a vital role in supporting patients with severe mental illness (SMI) by facilitating choice, supporting recovery and promoting evidence based guidelines. People with psychosis face 15 – 20 year premature mortality. New NICE guidance and the national CQUIN focus on improving the physical health of those with schizophrenia. The SMI population makes up 5% of the total population but accounts for 18% of total deaths. We must look beyond short term economic gains towards maintaining and improving the long term physical health as well as the mental health of patients.

12:45 - 13:30 Leader’s Forum (By invitation only) Tackling Winter Pressures Session led by Bupa Home Healthcare

16:15 - 17:00 Clinical Theatre

12:45 - 13:30 Keynote Theatre Update on NOACs and on-going clinical trials When are warfarin and aspirin not suitable (with patient-profile examples on how we manage a patient)? Helen Williams MRPharmS PGDip(Cardiol) Ipresc, Consultant Pharmacist for Cardiology, Lambeth & Southwark CCG, London and Sotiris Antoniou RPS MSc DipMgt, Consultant Pharmacist for Cardiology, Barts Health, London This session will primarily cover stroke prevention in atrial fibrillation with a focus on the current uptake of non-VKA oral anticoagulants (NOACs) across the UK. Cover the anticipated NICE AF guideline and the work on the NICE implementation collaborative with real cases of when warfarin and aspirin are not suitable and possible choices for managing these patients. Lastly highlight the ongoing clinical trials associated with NOACs.

12:45 - 13:30 Medicines Optimisation Workshops The wider role of pharmacists in delivering outcomes in diabetes Professor Ray Fitzpatrick, Clinical Director of Pharmacy, Royal Wolverhampton Hospitals NHS Trust, West Midlands Pharmacist Workforce Chair, Dr David Terry, Senior Lecturer in clinical pharmacy in the School of Life and Health Sciences, Aston University Birmingham and Mark Robinson, Medicines Management Partnership (London) Question today is ‘What can pharmacists do to empower people with diabetes?’ The session will be an interactive panel discussion to try and answer this central question. The discussion will help gain insight as to the role of pharmacist in diabetes management now and in the future.

Alcohol dependency – the problem, care pathways and new treatment opportunities for providers Simon Whitfield Clin Dip BPharm MRPharmS, Chief Pharmacist, Surrey & Borders Partnership NHS Foundation Trust This presentation gives an overview of the following: • The current burden presented by alcohol dependence in England, including the impact on NHS resources • The different thresholds and classification systems for establishing the severity of alcohol dependence • The current service providers, treatment pathways and interventions used including pharmacological abstinence strategies • The gaps in current treatment pathways • Opportunities for earlier intervention including the new pharmacological treatment nalmefene and its place in therapy • Opportunities for existing and new providers to support this public health agenda including a role for community.

12:45 - 13:30 Innovation & Technology Forum Supporting Aspectic Compounding Jonathan Fawdry MRPharmS, General Manager, Fagron UK Ltd To make it possible to provide personalised pharmaceutical care to patients, Industry needs to listen to its customers and work closely with prescribers, pharmacists and continue to develop a strategy of optimising and innovating pharmaceutical compounding. How can we help widen the therapeutic scope of the Prescriber and Compounding Pharmacist to offer bespoke pharmaceutical solutions and in particular the Aseptic Compounder, who needs leading-edge equipment with minimum validation requirements and innovative accessories to help reduce time-consuming repetitive manual operations and the opportunity for human error. How can we make life easier and more efficient for the Aseptic Compounder and ultimately much better and safer for the Patient.

Diabetes Breakfast Symposium delivered by Janssen

10:00 - 10:45 Clinical Theatre Treating DVT & PE, commissioning services and delivering QIPP - the smart outcome for patient and clinical choice. Sharron Gordon MRPharmS, Deputy Chief Pharmacist – Clinical Services, University Hospital Southampton and Frances Akor MPharm PhD MRPharmS IP , Consultant Pharmacist for Anticoagulation, Imperial Health & Chair of UKCPA Haemostasis, Anticoagulation & Thrombosis Committee. The session is designed to be as interactive as possible. Providing an opportunity to learn through some formal presentation but also an opportunity to learn through discussions with colleagues around patient case studies. The presentation will provide an overview of current drug therapy and treatment of VTE & PE. Changes in current practice across the country will be discussed and some of the challenges and opportunities presented by these changes, described. Learning will be reinforced through case studies and discussions with colleagues.

12:30 - 13:15 Clinical Theatre Almost a century of diabetes control, what next? Using recently introduced therapies in clinical practice Dr Rahul Nayar, Consultant in Diabetes and Endocrinology, Sunderland City Hospital Almost a century of diabetes control: achievements and remaining challenges Alia Gilani Bsc (Hons) MRPharmS MPC, Health Inequalities Pharmacist, NHS Glasgow Over time, approaches to type 2 diabetes care have evolved and the number of pharmacotherapies at healthcare professionals’ disposal to manage type 2 diabetes has grown. During this symposium, we will review some of the achievements and remaining challenges facing effective management of type 2 diabetes. We will then consider potential ways that you can improve the care available to people with type 2 diabetes in your clinical practice, both in terms of reconsidering therapeutic regimens and the services provided. There will also be an opportunity for you to pose your questions in a Question and Answer session.

12:45 - 13:30 Medicines Optimisation Workshops Interactive case based discussion on managing patient’s anticoagulation – interactive voting system presenting cases and then using the latest available evidence to find a suitable solution Helen Williams MRPharmS PGDip(Cardiol) Ipresc, Consultant Pharmacist for Cardiology, Lambeth & Southwark CCG, London and Sotiris Antoniou RPS MSc DipMgt, Consultant Pharmacist for Cardiology, Barts Health, London. A series of interesting cases involving anticoagulation whereby the audience can vote using an interactive voting system and debating the latest evidence to find a suitable solution.

All the above sessions are being delivered in conjunction with the companies as advertised.

Free Lunch

Register NOW at www.pharmacycongress.co.uk


www.pharmacycongress.co.uk

Horizon Strategic Partners Horizon Strategic Partners works in partnership with our clients in healthcare to design, implement and manage mobile technologies that increase productivity, reduce costs and improve outcomes. In 2013 Horizon launched their mobile health application, MicroGuide, since then 30 UK Hospital Trusts have acquired the service and there are 30,000 users of the service. MicroGuide is designed to allow pharmacists within a Trust to create their own local antimicrobial guidelines and publish them via the “cloud” to mobile users. Whenever the guideline is updated new versions are automatically sent to all users registered at that Trust and they will consequently always be working on the latest information at the “point of care”. The MicroGuide solution is provided as a service, via the Internet, so there is no requirement for any user or administrator of the solution to maintain or support either hardware or software for the duration of their service contract.

VISIT US AT STAND C58

Labmed Labmed cover all disciplines within Hospital Pharmacy job vacancies including Dispensing and Ward Pharmacists, Technicians, Aseptics and Accredited Checking Technicians. We have access to both locum and permanent job vacancies, many of which are exclusive to our agency as we have sole or preferred provider contracts with the NHS in London, Birmingham, Yorkshire, Humberside, East Midlands, Avon, Gloucestershire, Wiltshire, Cumbria and North West England. As well as Hospital based roles, Labmed also have access to MoD and HMP vacancies and currently have vacancies throughout the whole of the UK. Pharmacy locums undertake temporary assignments for a number of reasons. Many prefer to gain experience in different departments before accepting a permanent position, whilst the flexibility of working hours appeals to others to fund pension contributions or travel plans. Whatever your reasons, Labmed guarantees our candidates a quality service unrivalled in medical recruitment, ensuring you receive the most efficient service available.

VISIT US AT STAND G10

Polar Speed Temperature controlled pharmaceutical logistics. It’s Critical We Care – Over 15 years experience in the highly regulated world of pharmaceuticals, supporting the NHS and pharma industry with market leading supply chain solutions. Polar Speed offers dedicated facilities, extensive knowledge and compliance with regulatory standards for both the chilled and temperate market. We provide a One Stop Solution for all your patient, home delivery, inter hospital and external supplier temperature controlled logistics needs. We already offer these services to many pharma companies and over 80 NHS Trusts. • Quality and Compliance exceeding industry standards • ISO 9001:2008 accredited • Over 40,000 square feet of MHRA approved state-of-the-art warehousing • Nationwide Network • On-site and fully regulated pharmacy • Home delivery service to the homes of thousands of NHS and private patients. • Patient Co-ordinators • Direct to wards for named patients, bulk delivery etc. • Managed Diagnostic Service • Experienced staff delivering flexible and intelligent service • 130+ fleet of multi-temperature vehicles It’s Critical We Care – Because we all need pharmaceutical products to arrive in prime condition.

VISIT US AT STAND A35

19

Spirit Medical

Bupa Home Healthcare

SPIRIT MEDICAL LTD is an innovator in Healthcare products with particular expertise in drug delivery and infusion products. SPIRIT MEDICAL LTD continues it’s product development strategy in the quest for improved safety solutions, efficacy, and quality of infusion products that delver “true” value for money One of SPIRIT MEDICAL’s key aims is to fully understand our customers needs, delivering service excellence. Our partner for Infusion fluids MacoPharma has four manufacturing facilities in Europe, products are now sold into more than 55 countries worldwide. SPIRIT MEDICAL’s pharmacy products have a particular focus with in the following area’s: • STERI-TAMP 100% antibacterial seals – Also protecting giving tamper evidence for bags, vials and syringes • DOSI-FUSER ambulatory pumps for standard infusions • DOSI-PAIN ambulatory pumps for a range of pain control options • Large range of Needle Free infusion bags, especially developed for use in aseptic production facilities. ( helping services not only save money, increase capacity, but importantly complying with the new European directives ) • Consumable access and drug delivery products, including the ability to manufacture bespoke products quickly to the highest medical standards • Paracetamol Infusion bags, available in 50ml and 100ml non PVC More information available at www.spiritmedical.com Tel: 01332 206022, 300 City Gate Business Park, London Road, Derby, DE24 8WY.

Bupa Home Healthcare is the UK’s most experienced out-of-hospital healthcare provider. We don’t have any shareholders so any profits that we make get invested back into our services. We work alongside the NHS by providing high quality, tailored home healthcare services. Working closely with hospital pharmacists, clinicians and commissioners to deliver flexible healthcare solutions, we help providers meet their patient care targets and reduce waiting lists whilst ensuring patients continue to get the quality care they need in the comfort and convenience of their own home. Indeed 95% of our patients rate us services as excellent or good. Our experience covers a wide range of acute, complex and chronic medical treatments, as well as care packages covering infection management with IV antibiotics, home parenteral nutrition, multiple sclerosis and chemotherapy. To find out more please visit www.bupahomehealthcare.com or call 0800 688 8685.

VISIT US AT STAND G11

Primary Care Pharmacists’ Association The PCPA, established in 1999, is the largest and longest standing independent organisation dedicated to supporting pharmacists working within primary care. It is instrumental in: • Gathering and sharing best primary care pharmacy practice • Promoting the vital role played by primary care pharmacists in the UK • Provision of resources, support, networking, events and continuing professional development for members in strategic, operational and practice roles • Working with key organisations to promote the role of primary care pharmacists in the UK Until September 2014 the PCPA is offering primary care pharmacists FREE MEMBERSHIP – simply visit www.pcpa.org.uk to register. Tel: 01483 211092, Email: michelle@pcpa.org.uk

VISIT US AT STAND S10

Aclardian Aclardian is regulated by the MHRA for the supply of unlicensed medicines and is a trusted supplier of UK GMP batch manufactured and bespoke ‘Specials’. All our UK products are supplied with Certificates of Analysis/ Conformance. We also supply products imported from worldwide sources and which are unavailable in the UK. We are innovative; developing new products in response to clinical need including drugs for tube feeding and palatable forms of non-aqueous drugs. We also offer Medical Information and Pharmacovigilance assistance to Healthcare Professionals. Visit us at stand G12 or find out more at www.aclardian.com or call 01954 213490.

VISIT US AT STAND G12

VISIT US AT STAND B15

Mediwell Systems Ltd Mediwell Systems Ltd the award-winning supplier of the highly successful and innovative ‘Medi-365’ Medicines management systems built and developed in the UK. Our unique technically advanced systems include Medi-365, Grab and Go, Medi-Locker and Medi-Vend. Solutions that are successfully operating in numerous Hospital Emergency Departments and Wards throughout the UK. These cost effective Medi-365 systems continue to provide genuine improvements in efficiency, stock availability, patient care and safety, reducing drug errors and omissions, saving valuable time and money. Systems that are easy to use, versatile, totally controlled, providing high security especially in the management and supply of drugs and medicines. Medi-365 systems are designed to control numerous commodities including - Pharmacy OOH medicines, Clinical and Medical consumables, IV Fluids, Prosthetics etc. Want to save money without impacting on the continued delivery of an efficient and high quality service? Visit Mediwell on our stand for further information and demonstration, “Efficiency through Innovation”.

VISIT US AT STAND B21

NHS Protect NHS Protect leads on work to identify and tackle crime across the health service. It recently launched a ‘Medicine security self-assessment tool’ for use by chief pharmacists of hospital based pharmacy services in acute, mental health and community settings. The tool was developed with the support of the Chief Pharmaceutical Officer at the Department of Health and in consultation with the Care Quality Commission, Royal Pharmaceutical Society, and security specialists at NHS organisations. It will support chief pharmacists and their staff in their evaluation of organisational policies and procedures against guidance and legislative requirements for the secure management and storage of medicines, including controlled drugs. By completing this self-assessment tool organisations will be able to demonstrate that safe systems are in place or that they have reviewed their systems and processes and identified a course of action as a consequence of completing the audit.

VISIT US AT STAND A55

Read the latest news at www.pharmacycongress.co.uk

Register NOW at www.pharmacycongress.co.uk


g in ur (d

* EE H FR NC LU ) ns io ss se op sh rk wo

Farhana Karmali, Dispensing

Alison MacDonagh, Accessing automated dispensing machine

Jenny Morris, Examining medicinal leeches

Saagar Gohil, Dispensing

Caroline Lawrence, Inputting medicinal products to automated dispensing machine

Ganesh Vengadasalam, Reconstituting antibiotic powder

Grant O’Neill, Titration in Quality Control lab

Jaymi Teli, Aseptic preparation of medicinal product

Russell Ahmed, Spraying products into cytotoxic preparation room

Hasinaa Patel, Dispensing

Ingrid Xiques-Ramos, Preparation of sterile cytotoxic medications

Lionel Biu, Dispensing With thanks to the Pharmacy staff of the Royal Free London NHS Foundation Trust.

Your profession. Your future. Your event. Whatever your role in clinical pharmacy… we have it covered:

You can expect a faculty of world-class speakers, programmed by the Centre for Pharmacy Postgraduate Education (CPPE), the Royal Pharmaceutical Society (RPS) and the Commercial Medicines Unit (CMU) 54 hours of cutting-edge clinical content for your personal CPD

New medicines and specialist pharmacy technology and equipment suppliers to learn from (120) Celebrate the best of clinical pharmacy award winners Share best practice within the new Innovation & Technology mini-theatre

Network with 2,000 colleagues, peers and friends in the UK’s largest industry gathering

Delegate tickets are £499 + VAT (for one or two days). Please note a number of education passes have been distributed across UK NHS & Private Hospitals, NHS Trusts and industry associations, so please ask your Head of Department for your voucher code and access one of the limited FREE places TODAY.

Lead education partner: Leadership partner:

Education partners: Conference partners:

UK Renal Pharmacy Group

REGISTER NOW AT pharmacycongress.co.uk UK Ophthalmic Pharmacy Group

Accredited by: Media partners:


CPC Pre-show Newspaper 2014